TNK2
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
Y Sites Probabilities
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| A6NEC2 | Y173 | Sugiyama | NPEPPSL1 | NDKMKGFYRSKYTTPSGEVRyAAVTQFEATDARRAFPCWDE |
| A6NHL2 | Y319 | Sugiyama | TUBAL3 | TTACFESSNQLVKCDPRLGKyMACCLLyRGDVVPKEVNAAI |
| A6NMY6 | Y333 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | KsLyyyIQQDTKGDyQKALLyLCGGDD______________ |
| O00115 | Y53 | Sugiyama | DNASE2 DNASE2A DNL2 | YKLPALRGSGEAAQRGLQYKyLDEssGGWRDGRALINsPEG |
| O00115 | Y83 | Sugiyama | DNASE2 DNASE2A DNL2 | DGRALINsPEGAVGRSLQPLyRSNTSQLAFLLYNDQPPQPS |
| O00170 | Y203 | Sugiyama | AIP XAP2 | HQEGNRLYREGHVKEAAAKyyDAIACLKNLQMKEQPGSPEW |
| O00233 | Y41 | Sugiyama | PSMD9 | SDVQELMRRKEEIEAQIKANyDVLEsQKGIGMNEPLVDCEG |
| O00299 | Y233 | Sugiyama | CLIC1 G6 NCC27 | AyAREEFAstCPDDEEIELAyEQVAKALK____________ |
| O00401 | S242 | EPSD | WASL | GFDLNNLDPELKNLFDMCGIsEAQLKDRETSKVIyDFIEKT |
| O00401 | Y256 | EPSD|Sugiyama | WASL | FDMCGIsEAQLKDRETSKVIyDFIEKTGGVEAVKNELRRQA |
| O00429 | Y101 | Sugiyama | DNM1L DLP1 DRP1 | EENGVEAEEWGKFLHTKNKLyTDFDEIRQEIENETERISGN |
| O00625 | Y131 | Sugiyama | PIR | AHGLQLWVNLRSSEKMVEPQyQELKSEEIPKPSKDGVTVAV |
| O14818 | Y145 | Sugiyama | PSMA7 HSPC | RPFGISALIVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGA |
| O14818 | Y153 | Sugiyama | PSMA7 HSPC | IVGFDFDGTPRLyQtDPsGtyHAWKANAIGRGAKSVREFLE |
| O14828 | Y35 | Sugiyama | SCAMP3 C1orf3 PROPIN1 | sELDNPFQDPAVIQHRPsRQyATLDVyNPFETREPPPAyEP |
| O14950 | Y143 | Sugiyama | MYL12B MRLC2 MYLC2B | LRELLttMGDRFtDEEVDELyREAPIDKKGNFNyIEFtRIL |
| O14950 | Y156 | Sugiyama | MYL12B MRLC2 MYLC2B | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| O14974 | Y446 | Sugiyama | PPP1R12A MBS MYPT1 | EERKDEsPATWRLGLRKtGsyGALAEItASKEGQKEKDTAG |
| O14974 | Y901 | Sugiyama | PPP1R12A MBS MYPT1 | EtQtDsIsRyETssTsAGDRyDsLLGRsGsysYLEERKPYS |
| O15230 | Y81 | Sugiyama | LAMA5 KIAA0533 KIAA1907 | SATCGEEAPARGSPRPTEDLyCKLVGGPVAGGDPNQTIRGQ |
| O15234 | Y263 | Sugiyama | CASC3 MLN51 | DIRSAHNPDDIKPRRIRKPRyGsPPQRDPNWNGERLNKSHR |
| O43143 | Y254 | Sugiyama | DHX15 DBP1 DDX15 | KYMTDGMLLREAMNDPLLERyGVIILDEAHERTLATDILMG |
| O43164 | Y63 | Sugiyama | PJA2 KIAA0438 RNF131 | VSFKPCMTRHERSLGRAGDDyEVLELDDVPKENssGssPLD |
| O43390 | Y376 | Sugiyama | HNRNPR HNRPR | ILEKSFSEFGKLERVKKLKDyAFVHFEDRGAAVKAMDEMNG |
| O43464 | Y147 | Sugiyama | HTRA2 OMI PRSS25 | GPPAVLAAVPSPPPAsPRSQyNFIADVVEKTAPAVVYIEIL |
| O43707 | Y212 | Sugiyama | ACTN4 | WKDGLAFNALIHRHRPELIEyDKLRKDDPVTNLNNAFEVAE |
| O43707 | Y234 | Sugiyama | ACTN4 | KLRKDDPVTNLNNAFEVAEKyLDIPKMLDAEDIVNtARPDE |
| O43707 | Y906 | Sugiyama | ACTN4 | yQGPDAVPGALDyKsFStALyGEsDL_______________ |
| O43823 | Y311 | Sugiyama | AKAP8 AKAP95 | RGFDRFGPDGTGRKRKQFQLyEEPDtKLARVDsEGDFsEND |
| O43852 | Y106 | Sugiyama | CALU | GFVtVDELKDWIKFAQKRWIyEDVERQWKGHDLNEDGLVsW |
| O43852 | Y263 | Sugiyama | CALU | KNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNKDG |
| O60245 | Y180 | Sugiyama | PCDH7 BHPCDH | TLYLLPTATDRDFGRNGIERyELLQEPGGGGSGGESRRAGA |
| O60361 | Y136 | Sugiyama | NME2P1 | SLRFKPEELVDYKSCAHDWVyE___________________ |
| O60493 | Y71 | Sugiyama | SNX3 | IRVKTNLPIFKLKESTVRRRysDFEWLRSELERESKVVVPP |
| O60547 | Y159 | Sugiyama | GMDS | VKTCGLINSVKFYQASTSELyGKVQEIPQKETtPFYPRSPY |
| O60716 | Y228 | Sugiyama | CTNND1 KIAA0384 | yPPDGysRHyEDGyPGGsDNyGsLsRVtRIEERyRPsMEGy |
| O60814 | Y43 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| O75347 | Y75 | Sugiyama | TBCA | EILQEsRMMIPDCQRRLEAAyLDLQRILENEKDLEEAEEyK |
| O75688 | Y367 | Sugiyama | PPM1B PP2CB | IPNLPPGGGLAGKRNVIEAVySRLNPHREsDGAsDEAEEsG |
| O94906 | Y105 | Sugiyama | PRPF6 C20orf14 | AGSLFSSGPYEKDDEEADAIyAALDKRMDERRKERREQREK |
| O95425 | Y120 | Sugiyama | SVIL | SKAERIARYKAERRRQLAEKyGLTLDPEADsEyLsRYTKSR |
| O95714 | S2928 | Sugiyama | HERC2 | ILLGRIRAEEEDLAAVPFLAsDNEEEEDEKGNSGsLIRKKA |
| O95817 | Y247 | Sugiyama | BAG3 BIS | QAQKTHyPAQQGEyQtHQPVyHKIQGDDWEPRPLRAAsPFR |
| O95881 | Y137 | Sugiyama | TXNDC12 TLP19 UNQ713/PRO1376 | FLDPSGKVHPEIINENGNPsyKyFyVsAEQVVQGMKEAQER |
| P00338 | Y10 | Sugiyama | LDHA PIG19 | ___________MAtLKDQLIyNLLKEEQtPQNKITVVGVGA |
| P00338 | Y239 | Sugiyama | LDHA PIG19 | GtDKDKEQWKEVHKQVVEsAyEVIKLKGYtSWAIGLSVADL |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P00966 | Y207 | Sugiyama | ASS1 ASS | HIsyEAGILENPKNQAPPGLytKtQDPAKAPNtPDILEIEF |
| P02786 | Y402 | Sugiyama | TFRC | KEIKILNIFGVIKGFVEPDHyVVVGAQRDAWGPGAAKSGVG |
| P04406 | Y314 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | tFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsK |
| P04632 | Y87 | Sugiyama | CAPNS1 CAPN4 CAPNS | sAISEAAAQYNPEPPPPRtHysNIEANEsEEVRQFRRLFAQ |
| P05387 | Y7 | Sugiyama | RPLP2 D11S2243E RPP2 | ______________MRyVAsyLLAALGGNssPsAKDIKKIL |
| P05787 | Y286 | Sugiyama | KRT8 CYK8 | QyEDIANRsRAEAEsMyQIKyEELQsLAGKHGDDLRRTKTE |
| P06733 | Y270 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVV |
| P06733 | Y280 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | DFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDD |
| P06733 | Y407 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GLCtGQIKTGAPCRSERLAKyNQLLRIEEELGsKAKFAGRN |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07237 | Y94 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPK |
| P07355 | Y188 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | RKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVKRKGT |
| P07355 | Y333 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | KsLyyyIQQDTKGDyQKALLyLCGGDD______________ |
| P07737 | Y129 | Sugiyama | PFN1 | tLVLLMGKEGVHGGLINKKCyEMAsHLRRsQY_________ |
| P07814 | Y1504 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | KPLCELQPGAKCVCGKNPAKyytLFGRsy____________ |
| P07814 | Y1505 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PLCELQPGAKCVCGKNPAKyytLFGRsy_____________ |
| P07814 | Y827 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EIGQNIssNssAsILESKsLyDEVAAQGEVVRKLKAEKSPK |
| P07900 | Y284 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEEEEKKDGDKKKKKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P07900 | Y313 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | tKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P07900 | Y492 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLR |
| P07900 | Y61 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KEIFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLI |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | Y276 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P08238 | Y305 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P08238 | Y457 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LKLGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMK |
| P08238 | Y484 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVR |
| P08238 | Y56 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEIFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDII |
| P08670 | Y53 | Sugiyama | VIM | tsTRtYsLGsALRPstsRsLyAssPGGVyAtRssAVRLRss |
| P08708 | Y84 | Sugiyama | RPS17 RPS17L | GPVRGISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKE |
| P08865 | Y156 | Sugiyama | RPSA LAMBR LAMR1 | EAsyVNLPtIALCNTDSPLRyVDIAIPCNNKGAHSVGLMWW |
| P09104 | T41 | Sugiyama | ENO2 | EVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKG |
| P09104 | Y44 | Sugiyama | ENO2 | LyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKGVLK |
| P09211 | Y50 | Sugiyama | GSTP1 FAEES3 GST3 | KEEVVTVETWQEGsLKASCLyGQLPKFQDGDLtLyQsNtIL |
| P10275 | Y269 | EPSD|PSP | AR DHTR NR3C4 | LGVEALEHLsPGEQLRGDCMyAPLLGVPPAVRPtPCAPLAE |
| P10275 | Y365 | EPSD|PSP | AR DHTR NR3C4 | LSLYKSGALDEAAAYQSRDYyNFPLALAGPPPPPPPPHPHA |
| P10275 | Y535 | PSP | AR DHTR NR3C4 | PsPTCVKSEMGPWMDSYSGPyGDMRLETARDHVLPIDYYFP |
| P10398 | Y155 | Sugiyama | ARAF ARAF1 PKS PKS2 | HCSSKVPTVCVDMSTNRQQFyHsVQDLsGGsRQHEAPsNRP |
| P10809 | Y243 | Sugiyama | HSPD1 HSP60 | yIsPyFINtsKGQKCEFQDAyVLLsEKKIssIQsIVPALEI |
| P11142 | Y41 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P11940 | Y291 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | ERQTELKRKFEQMKQDRITRyQGVNLyVKNLDDGIDDERLR |
| P12814 | Y215 | Sugiyama | ACTN1 | KLRKDDPLTNLNTAFDVAEKyLDIPKMLDAEDIVGtARPDE |
| P12814 | Y842 | Sugiyama | ACTN1 | DTDTADQVMASFKILAGDKNyITMDELRRELPPDQAEyCIA |
| P13010 | Y316 | Sugiyama | XRCC5 G22P2 | CLNDDDETEVLKEDIIQGFRyGsDIVPFSKVDEEQMKYKSE |
| P13639 | Y634 | Sugiyama | EEF2 EF2 | AEDIDKGEVsARQELKQRARyLAEKyEWDVAEARKIWCFGP |
| P13639 | Y639 | Sugiyama | EEF2 EF2 | KGEVsARQELKQRARyLAEKyEWDVAEARKIWCFGPDGTGP |
| P13639 | Y730 | Sugiyama | EEF2 EF2 | HADAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQ |
| P13667 | Y273 | Sugiyama | PDIA4 ERP70 ERP72 | PTLKIFRKGRPYDYNGPREKyGIVDyMIEQSGPPSKEILTL |
| P13796 | Y124 | Sugiyama | LCP1 PLS2 | GGtsEQssVGtQHsysEEEKyAFVNWINKALENDPDCRHVI |
| P13797 | Y127 | Sugiyama | PLS3 | GGTsELssEGtQHsysEEEKyAFVNWINKALENDPDCRHVI |
| P13929 | T41 | Sugiyama | ENO3 | EVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKG |
| P13929 | Y44 | Sugiyama | ENO3 | LHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKGVLK |
| P14314 | T469 | Sugiyama | PRKCSH G19P1 | WGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLCGKEt |
| P14324 | Y349 | Sugiyama | FDPS FPS KIAA1293 | QDNKCSWLVVQCLQRATPEQyQILKENYGQKEAEKVARVKA |
| P14625 | Y539 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | tDItsLDQyVERMKEKQDKIyFMAGsSRKEAEssPFVERLL |
| P14649 | S87 | Sugiyama | MYL6B MLC1SA | EEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVLK |
| P14649 | Y86 | Sugiyama | MYL6B MLC1SA | LEEFKEAFELFDRVGDGKILysQCGDVMRALGQNPtNAEVL |
| P14854 | Y57 | Sugiyama | COX6B1 COX6B | FHRCQKAMTAKGGDIsVCEWyQRVYQsLCPtsWVTDWDEQR |
| P15259 | Y92 | Sugiyama | PGAM2 PGAMM | DGTDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEEQV |
| P15880 | Y248 | Sugiyama | RPS2 RPS4 | GCtAtLGNFAKATFDAISKTysyLtPDLWKEtVFtKsPyQE |
| P15880 | Y250 | Sugiyama | RPS2 RPS4 | tAtLGNFAKATFDAISKTysyLtPDLWKEtVFtKsPyQEFt |
| P16070 | Y79 | Sugiyama | CD44 LHR MDU2 MDU3 MIC4 | TLPTMAQMEKALsIGFEtCRyGFIEGHVVIPRIHPNSICAA |
| P17066 | Y43 | Sugiyama | HSPA6 HSP70B' | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P17676 | Y137 | Sugiyama | CEBPB TCF5 PP9092 | FLSDLFSDDYGGKNCKKPAEyGyVsLGRLGAAKGALHPGCF |
| P17676 | Y139 | Sugiyama | CEBPB TCF5 PP9092 | SDLFSDDYGGKNCKKPAEyGyVsLGRLGAAKGALHPGCFAP |
| P17812 | Y468 | Sugiyama | CTPS1 CTPS | MRLGKRRtLFQTKNsVMRKLyGDADyLEERHRHRFEVNPVW |
| P17980 | Y185 | Sugiyama | PSMC3 TBP1 | PtEyDsRVKAMEVDERPtEQysDIGGLDKQIQELVEAIVLP |
| P17980 | Y381 | Sugiyama | PSMC3 TBP1 | ARARIMQIHSRKMNVsPDVNyEELARCTDDFNGAQCKAVCV |
| P18206 | Y822 | Sugiyama | VCL | KAVAGNIsDPGLQKsFLDsGyRILGAVAKVREAFQPQEPDF |
| P18615 | Y133 | Sugiyama | NELFE RD RDBP | sIsADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEA |
| P18615 | Y367 | Sugiyama | NELFE RD RDBP | SLAVQNsPKGCHRDKRTQIVysDDVyKENLVDGF_______ |
| P18669 | S137 | Sugiyama | PGAM1 PGAMA CDABP0006 | RsyDVPPPPMEPDHPFysNIsKDRRyADLtEDQLPsCEsLK |
| P18669 | Y119 | Sugiyama | PGAM1 PGAMA CDABP0006 | NKAETAAKHGEAQVKIWRRsyDVPPPPMEPDHPFysNIsKD |
| P18669 | Y142 | Sugiyama | PGAM1 PGAMA CDABP0006 | PPPPMEPDHPFysNIsKDRRyADLtEDQLPsCEsLKDtIAR |
| P18669 | Y92 | Sugiyama | PGAM1 PGAMA CDABP0006 | DAIDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQV |
| P19105 | Y142 | Sugiyama | MYL12A MLCB MRLC3 RLC | LRELLttMGDRFtDEEVDELyREAPIDKKGNFNyIEFtRIL |
| P19105 | Y155 | Sugiyama | MYL12A MLCB MRLC3 RLC | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| P19338 | Y462 | Sugiyama | NCL | AEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWs |
| P20618 | Y150 | Sugiyama | PSMB1 PSC5 | FPYYVYNIIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSAS |
| P20674 | Y80 | Sugiyama | COX5A | FNKPDIDAWELRKGINTLVTyDMVPEPKIIDAALRACRRLN |
| P22234 | Y22 | Sugiyama | PAICS ADE2 AIRC PAIS | AtAEVLNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAG |
| P22314 | Y451 | Sugiyama | UBA1 A1S9T UBE1 | CLPEDKEVLTEDKCLQRQNRyDGQVAVFGsDLQEKLGKQKY |
| P22314 | Y55 | Sugiyama | UBA1 A1S9T UBE1 | SVPTNGMAKNGsEADIDEGLysRQLyVLGHEAMKRLQTSSV |
| P22392 | Y151 | Sugiyama | NME2 NM23B | SLWFKPEELVDyKSCAHDWVyE___________________ |
| P22626 | Y336 | Sugiyama | HNRNPA2B1 HNRPA2B1 | MKsGNFGGsRNMGGPyGGGNyGPGGsGGsGGyGGRsRy___ |
| P23434 | Y139 | Sugiyama | GCSH | EVTEINEALAENPGLVNKSCyEDGWLIKMtLsNPsELDELM |
| P23470 | Y92 | Sugiyama | PTPRG PTPG | VTSSVSCGGRHQSPIDILDQyARVGEEYQELQLDGFDNESS |
| P23528 | Y140 | Sugiyama | CFL1 CFL | SKDAIKKKLtGIKHELQANCyEEVKDRCTLAEKLGGsAVIs |
| P23528 | Y68 | Sugiyama | CFL1 CFL | ILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAt |
| P23528 | Y82 | Sugiyama | CFL1 CFL | QtVDDPyAtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFI |
| P23528 | Y85 | Sugiyama | CFL1 CFL | DDPyAtFVKMLPDKDCRyALyDAtyEtKESKKEDLVFIFWA |
| P23588 | Y593 | Sugiyama | EIF4B | APEPKKPEENPASKFssASKyAALsVDGEDENEGEDyAE__ |
| P24752 | Y90 | Sugiyama | ACAT1 ACAT MAT | IAIQGAIEKAGIPKEEVKEAyMGNVLQGGEGQAPTRQAVLG |
| P25205 | Y708 | Sugiyama | MCM3 | KRKRRKTRQPDAKDGDsyDPyDFsDtEEEMPQVHtPKTADs |
| P25208 | Y58 | Sugiyama | NFYB HAP3 | SMNDHEDTNGSKESFREQDIyLPIANVARIMKNAIPQTGKI |
| P25685 | Y52 | Sugiyama | DNAJB1 DNAJ1 HDJ1 HSPF1 | HPDKNKEPGAEEKFKEIAEAyDVLSDPRKREIFDRYGEEGL |
| P25685 | Y6 | Sugiyama | DNAJB1 DNAJ1 HDJ1 HSPF1 | _______________MGKDyyQTLGLARGAsDEEIKRAYRR |
| P25705 | Y243 | PSP | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | IDtIINQKRFNDGsDEKKKLyCIyVAIGQKRsTVAQLVKRL |
| P25705 | Y246 | PSP | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | IINQKRFNDGsDEKKKLyCIyVAIGQKRsTVAQLVKRLTDA |
| P25786 | Y6 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | _______________MFRNQyDNDVtVWsPQGRIHQIEYAM |
| P26599 | Y127 | Sugiyama | PTBP1 PTB | ANTMVNYYTSVTPVLRGQPIyIQFsNHKELKtDSSPNQARA |
| P27348 | Y149 | Sugiyama | YWHAQ | LAEVACGDDRKQtIDNsQGAyQEAFDIsKKEMQPTHPIRLG |
| P27348 | Y19 | Sugiyama | YWHAQ | __MEKTELIQKAKLAEQAERyDDMAtCMKAVtEQGAELsNE |
| P27348 | Y48 | Sugiyama | YWHAQ | AVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSIEQK |
| P27695 | Y128 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | LQELPGLSHQYWSAPsDKEGysGVGLLsRQCPLKVsyGIGD |
| P27695 | Y45 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | KSKTAAKKNDKEAAGEGPALyEDPPDQKtsPsGKPAtLKIC |
| P27816 | Y47 | Sugiyama | MAP4 | AtLEAEAFDDVVGETVGKTDyIPLLDVDEKtGNsESKKKPC |
| P29353 | Y427 | Sugiyama | SHC1 SHC SHCA | RKQMPPPPPCPGRELFDDPsyVNVQNLDKARQAVGGAGPPN |
| P29401 | Y481 | Sugiyama | TKT | AANTKGICFIRTsRPENAIIyNNNEDFQVGQAKVVLKSKDD |
| P29692 | Y26 | Sugiyama | EEF1D EF1D | LAHEKIWFDKFKYDDAERRFyEQMNGPVAGAsRQENGAsVI |
| P30043 | Y205 | Sugiyama | BLVRB FLR SCAN | MLRCLttDEyDGHstyPsHQyQ___________________ |
| P30085 | Y27 | Sugiyama | CMPK1 CMK CMPK UCK UMK UMPK | FVLGGPGAGKGTQCARIVEKyGytHLSAGELLRDERKNPDs |
| P30085 | Y49 | Sugiyama | CMPK1 CMK CMPK UCK UMK UMPK | ytHLSAGELLRDERKNPDsQyGELIEKYIKEGKIVPVEITI |
| P30086 | T65 | Sugiyama | PEBP1 PBP PEBP | QVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREWH |
| P30086 | Y120 | Sugiyama | PEBP1 PBP PEBP | GtVLsDyVGsGPPKGtGLHRyVWLVyEQDRPLKCDEPILsN |
| P30086 | Y64 | Sugiyama | PEBP1 PBP PEBP | tQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREW |
| P30101 | Y67 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LMLVEFFAPWCGHCKRLAPEyEAAAtRLKGIVPLAKVDCTA |
| P30101 | Y95 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KGIVPLAKVDCTANTNTCNKyGVsGyPtLKIFRDGEEAGAy |
| P30622 | Y108 | Sugiyama | CLIP1 CYLN1 RSN | AGIVLDEPIGKNDGSVAGVRyFQCEPLKGIFTRPSKLTRKV |
| P31749 | Y176 | SIGNOR|EPSD | AKT1 PKB RAC | LGKGTFGKVILVKEKATGRYyAMKILKKEVIVAKDEVAHtL |
| P31943 | Y266 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | yNGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQst |
| P31946 | Y151 | Sugiyama | YWHAB | LsEVAsGDNKQTtVsNsQQAyQEAFEIsKKEMQPTHPIRLG |
| P31946 | Y50 | Sugiyama | YWHAB | AVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P31947 | Y151 | Sugiyama | SFN HME1 | LAEVATGDDKKRIIDSARsAyQEAMDISKKEMPPTNPIRLG |
| P31947 | Y48 | Sugiyama | SFN HME1 | GAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsIEQK |
| P31948 | Y354 | Sugiyama | STIP1 | DVLKKCQQAEKILKEQERLAyINPDLALEEKNKGNECFQKG |
| P32119 | Y115 | Sugiyama | PRDX2 NKEFB TDPX1 | GLGPLNIPLLADVTRRLsEDyGVLKTDEGIAYRGLFIIDGK |
| P32969 | Y180 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | LIQQATTVKNKDIRKFLDGIyVsEKGtVQQADE________ |
| P33121 | Y693 | Sugiyama | ACSL1 FACL1 FACL2 LACS LACS1 LACS2 | TMKAKRPELRNYFRSQIDDLyStIKV_______________ |
| P33316 | Y167 | Sugiyama | DUT | PPMEKAVVKTDIQIALPsGCyGRVAPRSGLAAKHFIDVGAG |
| P33991 | Y394 | Sugiyama | MCM4 CDC21 | AHNDLVDKVQPGDRVNVTGIyRAVPIRVNPRVSNVKSVYKT |
| P34931 | Y43 | Sugiyama | HSPA1L | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P36871 | Y157 | Sugiyama | PGM1 | GPAPEAITDKIFQISKTIEEyAVCPDLKVDLGVLGKQQFDL |
| P37802 | Y192 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NVIGLQMGtNRGAsQAGMtGyGMPRQIL_____________ |
| P37837 | Y206 | Sugiyama | TALDO1 TAL TALDO TALDOR | ISPFVGRILDWHVANTDKKSyEPLEDPGVKSVTKIYNYYKK |
| P38117 | Y192 | Sugiyama | ETFB FP585 | tLRLKLPAVVTADLRLNEPRyAtLPNIMKAKKKKIEVIKPG |
| P39019 | Y48 | Sugiyama | RPS19 | LKVPEWVDtVKLAKHKELAPyDENWFytRAAstARHLYLRG |
| P40429 | Y149 | Sugiyama | RPL13A | LKPTRKFAYLGRLAHEVGWKyQAVtAtLEEKRKEKAKIHYR |
| P40925 | Y210 | Sugiyama | MDH1 MDHA | tQYPDVNHAKVKLQGKEVGVyEALKDDsWLKGEFVttVQQR |
| P42768 | Y291 | EPSD|PSP | WAS IMD2 | FSRAGIsEAQLtDAETsKLIyDFIEDQGGLEAVRQEMRRQE |
| P43243 | Y214 | Sugiyama | MATR3 KIAA0723 | PsLNPVLDyDHGsRsQEsGyyDRMDyEDDRLRDGERCRDDs |
| P46778 | Y30 | Sugiyama | RPL21 | GTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQK |
| P46940 | Y1478 | Sugiyama | IQGAP1 KIAA0051 | KIQTGLKKLTELGtVDPKNKyQELINDIARDIRNQRRYRQR |
| P47224 | Y114 | Sugiyama | RABIF MSS4 RASGRF3 | CADCEIGPIGWHCLDDKNSFyVALERVSHE___________ |
| P48741 | Y43 | Sugiyama | HSPA7 HSP70B | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P49321 | Y540 | Sugiyama | NASP | DMLDLAKIIFKRQETKEAQLyAAQAHLKLGEVSVESENYVQ |
| P49327 | S2032 | Sugiyama | FASN FAS | ELDYFVVFSSVSCGRGNAGQsNyGFANsAMERICEKRRHEG |
| P49327 | Y45 | Sugiyama | FASN FAS | NLIGGVDMVTDDDRRWKAGLyGLPRRsGKLKDLSRFDAsFF |
| P49588 | Y192 | Sugiyama | AARS1 AARS | KDNFWEMGDtGPCGPCsEIHyDRIGGRDAAHLVNQDDPNVL |
| P50402 | Y161 | Sugiyama | EMD EDMD STA | sssEEECKDRERPMYGRDsAyQsItHyRPVsAsRssLDLsy |
| P50402 | Y167 | Sugiyama | EMD EDMD STA | CKDRERPMYGRDsAyQsItHyRPVsAsRssLDLsyyPTSSS |
| P50990 | Y30 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | GFAQMLKEGAKHFsGLEEAVyRNIQACKELAQTTRTAYGPN |
| P51692 | T684 | Sugiyama | STAT5B | NYLIYVFPDRPKDEVySKyytPVPCESATAKAVDGyVKPQI |
| P51692 | Y683 | Sugiyama | STAT5B | LNYLIYVFPDRPKDEVySKyytPVPCESATAKAVDGyVKPQ |
| P51812 | S708 | Sugiyama | RPS6KA3 ISPK1 MAPKAPK1B RSK2 | YQLNRQDAPHLVKGAMAAtysALNRNQsPVLEPVGRsTLAQ |
| P51812 | Y707 | Sugiyama | RPS6KA3 ISPK1 MAPKAPK1B RSK2 | QYQLNRQDAPHLVKGAMAAtysALNRNQsPVLEPVGRsTLA |
| P52272 | Y681 | Sugiyama | HNRNPM HNRPM NAGR1 | PFDFTWKMLKDKFNECGHVLyADIKMENGKSKGCGVVKFEs |
| P52565 | Y156 | Sugiyama | ARHGDIA GDIA1 | GVKIDKtDyMVGsYGPRAEEyEFLtPVEEAPKGMLARGsYs |
| P52597 | Y82 | Sugiyama | HNRNPF HNRPF | GsEDDVKMALKKDRESMGHRyIEVFKSHRTEMDWVLKHsGP |
| P54105 | Y38 | Sugiyama | CLNS1A CLCI ICLN | RQQPDTEAVLNGKGLGtGtLyIAEsRLSWLDGsGLGFSLEY |
| P54577 | Y289 | Sugiyama | YARS1 YARS | FPLKSEFVILRDEKWGGNKTytAyVDLEKDFAAEVVHPGDL |
| P54652 | Y42 | Sugiyama | HSPA2 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P55196 | Y1497 | Sugiyama | AFDN AF6 MLLT4 | VIRELQPQQQPRTIERRDLQyItVsKEELssGDsLsPDPWK |
| P55209 | Y106 | Sugiyama | NAP1L1 NRP | VKCAQIEAKFyEEVHDLERKyAVLyQPLFDKRFEIINAIYE |
| P55209 | Y110 | Sugiyama | NAP1L1 NRP | QIEAKFyEEVHDLERKyAVLyQPLFDKRFEIINAIYEPTEE |
| P55327 | Y136 | Sugiyama | TPD52 | LQELKQNIAKGWQDVTATSAyKKTSETLSQAGQKASAAFSS |
| P55786 | Y173 | Sugiyama | NPEPPS PSA | NDKMKGFYRSKYTTPSGEVRyAAVTQFEATDARRAFPCWDE |
| P55795 | Y266 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | YGGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQst |
| P55884 | Y306 | Sugiyama | EIF3B EIF3S9 | PFKDLGNLRYWLEEAECRDQysVIFESGDRTSIFWNDVKDP |
| P56945 | Y12 | Sugiyama | BCAR1 CAS CASS1 CRKAS | _________MNHLNVLAKALyDNVAEsPDELSFRKGDIMTV |
| P57053 | Y43 | Sugiyama | H2BC12L H2BFS H2BS1 | QKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| P58876 | Y43 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| P60174 | Y209 | Sugiyama | TPI1 TPI | LRGWLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDG |
| P60660 | S30 | Sugiyama | MYL6 | AEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVLK |
| P60660 | Y29 | Sugiyama | MYL6 | TAEFKEAFQLFDRtGDGKILysQCGDVMRALGQNPtNAEVL |
| P60660 | Y89 | Sugiyama | MYL6 | HFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMGAEI |
| P60709 | T297 | Sugiyama | ACTB | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P60709 | Y198 | Sugiyama | ACTB | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60709 | Y294 | Sugiyama | ACTB | IHETTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQ |
| P60842 | Y197 | Sugiyama | EIF4A1 DDX2A EIF4A | KMFVLDEADEMLsRGFKDQIyDIFQKLNsNtQVVLLSATMP |
| P60842 | Y70 | Sugiyama | EIF4A1 DDX2A EIF4A | yGFEKPsAIQQRAILPCIKGyDVIAQAQsGtGKTATFAISI |
| P60900 | Y160 | Sugiyama | PSMA6 PROS27 | LIGIDEEQGPQVYKCDPAGyyCGFKATAAGVKQtEstsFLE |
| P61024 | Y12 | Sugiyama | CKS1B CKS1 PNAS-143 PNAS-16 | _________MSHKQIyysDKyDDEEFEyRHVMLPKDIAKLV |
| P61158 | S232 | Sugiyama | ACTR3 ARP3 | EVGIPPEQSLETAKAVKERysyVCPDLVKEFNKYDTDGSKW |
| P61247 | Y256 | Sugiyama | RPS3A FTE1 MFTL | sssGKAtGDEtGAKVERADGyEPPVQEsV____________ |
| P61353 | Y77 | Sugiyama | RPL27 | MGKKKIAKRSKIKSFVKVyNyNHLMPtRysVDIPLDKtVVN |
| P61353 | Y85 | Sugiyama | RPL27 | RSKIKSFVKVyNyNHLMPtRysVDIPLDKtVVNKDVFRDPA |
| P61604 | Y100 | Sugiyama | HSPE1 | KVVLDDKDyFLFRDGDILGKyVD__________________ |
| P61981 | Y49 | Sugiyama | YWHAG | NVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P62081 | Y177 | Sugiyama | RPS7 | HLDKAQQNNVEHKVEtFsGVyKKLTGKDVNFEFPEFQL___ |
| P62191 | Y184 | Sugiyama | PSMC1 | MDDTDPLVTVMKVEKAPQETyADIGGLDNQIQEIKESVELP |
| P62249 | Y115 | Sugiyama | RPS16 | YYQKYVDEASKKEIKDILIQyDRtLLVADPRRCESKKFGGP |
| P62258 | Y152 | Sugiyama | YWHAE | LAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHPIRLG |
| P62258 | Y49 | Sugiyama | YWHAE | KVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssIEQK |
| P62269 | S96 | Sugiyama | RPS18 D6S218E | QYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLKK |
| P62269 | Y95 | Sugiyama | RPS18 D6S218E | RQYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLK |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62750 | Y144 | Sugiyama | RPL23A | VNtLIRPDGEKKAYVRLAPDyDALDVANKIGII________ |
| P62750 | Y74 | Sugiyama | RPL23A | LRRQPKYPRKSAPRRNKLDHyAIIKFPLTTEsAMKKIEDNN |
| P62805 | Y89 | EPSD | H4C1 H4/A H4FA HIST1H4A; H4C2 H4/I H4FI HIST1H4B; H4C3 H4/G H4FG HIST1H4C; H4C4 H4/B H4FB HIST1H4D; H4C5 H4/J H4FJ HIST1H4E; H4C6 H4/C H4FC HIST1H4F; H4C8 H4/H H4FH HIST1H4H; H4C9 H4/M H4FM HIST1H4I; H4C11 H4/E H4FE HIST1H4J; H4C12 H4/D H4FD HIST1H4K; H4C13 H4/K H4FK HIST1H4L; H4C14 H4/N H4F2 H4FN HIST2H4 HIST2H4A; H4C15 H4/O H4FO HIST2H4B; H4C16 H4-16 HIST4H4 | DAVtyTEHAKRKtVTAMDVVyALKRQGRTLYGFGG______ |
| P62807 | Y43 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | QKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| P62826 | Y146 | Sugiyama | RAN ARA24 OK/SW-cl.81 | IKDRKVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLAR |
| P62826 | Y147 | Sugiyama | RAN ARA24 OK/SW-cl.81 | KDRKVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLARK |
| P62906 | Y11 | Sugiyama | RPL10A NEDD6 | __________MSSKVsRDtLyEAVREVLHGNQRKRRKFLET |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62942 | Y27 | Sugiyama | FKBP1A FKBP1 FKBP12 | tIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRDRNKPF |
| P63104 | Y149 | Sugiyama | YWHAZ | LAEVAAGDDKKGIVDQsQQAyQEAFEIsKKEMQPTHPIRLG |
| P63104 | Y19 | Sugiyama | YWHAZ | __MDKNELVQKAKLAEQAERyDDMAACMKsVtEQGAELsNE |
| P63104 | Y48 | Sugiyama | YWHAZ | sVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssIEQK |
| P63173 | Y41 | Sugiyama | RPL38 | KSVKIKKNKDNVKFKVRCSRyLytLVItDKEKAEKLKQSLP |
| P63173 | Y43 | Sugiyama | RPL38 | VKIKKNKDNVKFKVRCSRyLytLVItDKEKAEKLKQSLPPG |
| P63220 | T52 | Sugiyama | RPS21 | IQMNVAEVDKVTGRFNGQFKtyAICGAIRRMGEsDDsILRL |
| P63261 | T297 | Sugiyama | ACTG1 ACTG | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P63261 | Y198 | Sugiyama | ACTG1 ACTG | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63261 | Y294 | Sugiyama | ACTG1 ACTG | IHETTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQ |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P67809 | Y208 | Sugiyama | YBX1 NSEP1 YB1 | yRRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGE |
| P67809 | Y72 | Sugiyama | YBX1 NSEP1 YB1 | KKVIATKVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68104 | Y29 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| P68104 | Y86 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | ERERGITIDISLWKFEtsKyyVtIIDAPGHRDFIKNMITGT |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68363 | Y312 | Sugiyama | TUBA1B | tNACFEPANQMVKCDPRHGKyMACCLLyRGDVVPKDVNAAI |
| P68366 | Y312 | Sugiyama | TUBA4A TUBA1 | tNACFEPANQMVKCDPRHGKyMACCLLyRGDVVPKDVNAAI |
| P78318 | Y277 | Sugiyama | IGBP1 IBP1 | AGYPSLPTMTVSDWYEQHRKyGALPDQGIAKAAPEEFRKAA |
| P84103 | Y33 | Sugiyama | SRSF3 SFRS3 SRP20 | yVGNLGNNGNKtELERAFGyyGPLRSVWVARNPPGFAFVEF |
| P98175 | Y694 | Sugiyama | RBM10 DXS8237E GPATC9 GPATCH9 KIAA0122 | QPISSLRDDERREsAtADAGyAILEKKGALAERQHTsMDLP |
| Q00341 | Y358 | Sugiyama | HDLBP HBP VGL | SETVILRGEPEKLGQALTEVyAKANsFTVSSVAAPSWLHRF |
| Q02878 | Y115 | Sugiyama | RPL6 TXREB1 | PVGGDKNGGTRVVKLRKMPRyyPtEDVPRKLLSHGKKPFSQ |
| Q04721 | T128 | Sugiyama | NOTCH2 | PCFVSRPCLNGGTCHMLSRDtyECtCQVGFTGKECQWTDAC |
| Q04721 | T132 | Sugiyama | NOTCH2 | SRPCLNGGTCHMLSRDtyECtCQVGFTGKECQWTDACLSHP |
| Q04721 | Y129 | Sugiyama | NOTCH2 | CFVSRPCLNGGTCHMLSRDtyECtCQVGFTGKECQWTDACL |
| Q04760 | Y49 | Sugiyama | GLO1 | DFLLQQtMLRVKDPKKSLDFyTRVLGMtLIQKCDFPIMKFS |
| Q04917 | Y49 | Sugiyama | YWHAH YWHA1 | AVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSIEQK |
| Q05639 | Y29 | Sugiyama | EEF1A2 EEF1AL STN | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| Q06830 | Y116 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | GLGPMNIPLVSDPKRtIAQDyGVLKADEGIsFRGLFIIDDK |
| Q07912 | T430 | Sugiyama | TNK2 ACK1 | NDVITVIEGRAENyWWRGQNtRtLCVGPFPRNVVTsVAGLS |
| Q07912 | T432 | Sugiyama | TNK2 ACK1 | VITVIEGRAENyWWRGQNtRtLCVGPFPRNVVTsVAGLSAQ |
| Q07912 | Y284 | SIGNOR|ELM|iPTMNet|EPSD|PSP|Sugiyama | TNK2 ACK1 | DLVKIGDFGLMRALPQNDDHyVMQEHRKVPFAWCAPESLKT |
| Q07912 | Y423 | Sugiyama | TNK2 ACK1 | DKLHIQMNDVITVIEGRAENyWWRGQNtRtLCVGPFPRNVV |
| Q07912 | Y859 | PSP | TNK2 ACK1 | RAGPCILPIVRDGKKVsstHyyLLPERPSYLERYQRFLREA |
| Q07912 | Y860 | PSP | TNK2 ACK1 | AGPCILPIVRDGKKVsstHyyLLPERPSYLERYQRFLREAQ |
| Q08043 | Y229 | Sugiyama | ACTN3 | KLRKDDPIGNLNTAFEVAEKyLDIPKMLDAEDIVNtPKPDE |
| Q12874 | Y50 | Sugiyama | SF3A3 SAP61 | KSTLRDQINSDHRTRAMQDRyMEVSGNLRDLyDDKDGLRKE |
| Q12906 | Y579 | Sugiyama | ILF3 DRBF MPHOSPH4 NF90 | VEVDGQKFQGAGSNKKVAKAyAALAALEKLFPDtPLALDAN |
| Q13155 | Y35 | Sugiyama | AIMP2 JTV1 PRO0992 | PLRVELPTCMYRLPNVHGRSyGPAPGAGHVQEEsNLsLQAL |
| Q13177 | Y139 | Sugiyama | PAK2 | NPQAVLDVLKFyDsNtVKQKyLsFtPPEKDGFPsGtPALNA |
| Q13263 | S757 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | TLDLTLIRARLQEKLsPPyssPQEFAQDVGRMFKQFNKLTE |
| Q13263 | Y755 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | GGTLDLTLIRARLQEKLsPPyssPQEFAQDVGRMFKQFNKL |
| Q13435 | Y639 | Sugiyama | SF3B2 SAP145 | MPVGPNAHKVPPPWLIAMQRyGPPPSyPNLKIPGLNsPIPE |
| Q13442 | S19 | Sugiyama | PDAP1 HASPP28 | __MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEEE |
| Q13442 | T18 | Sugiyama | PDAP1 HASPP28 | ___MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEE |
| Q13442 | Y17 | Sugiyama | PDAP1 HASPP28 | ____MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREE |
| Q13561 | Y313 | Sugiyama | DCTN2 DCTN50 | IAKHKASVEDADTQSKVHQLyEtIQRWsPIASTLPELVQRL |
| Q13561 | Y6 | Sugiyama | DCTN2 DCTN50 | _______________MADPKyADLPGIARNEPDVYETSDLP |
| Q13765 | Y120 | Sugiyama | NACA HSD48 | KNILFVITKPDVYKSPAsDtyIVFGEAKIEDLsQQAQLAAA |
| Q14157 | S859 | Sugiyama | UBAP2L KIAA0144 NICE4 | FPtPttPLtGRDGsLAsNPysGDLtKFGRGDASSPAPATTL |
| Q14157 | Y858 | Sugiyama | UBAP2L KIAA0144 NICE4 | PFPtPttPLtGRDGsLAsNPysGDLtKFGRGDASSPAPATT |
| Q14204 | Y2265 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | EGVEGVAHIIDPKAISKDHLyGtLDPNTREWTDGLFTHVLR |
| Q14240 | Y71 | Sugiyama | EIF4A2 DDX2B EIF4F | yGFEKPsAIQQRAIIPCIKGyDVIAQAQsGtGKTATFAISI |
| Q14247 | Y334 | Sugiyama | CTTN EMS1 | KDRMDKNAstFEDVtQVssAyQKTVPVEAVtsKtsNIRANF |
| Q14247 | Y538 | Sugiyama | CTTN EMS1 | IITNIEMIDDGWWRGVCKGRyGLFPANyVELRQ________ |
| Q14247 | Y545 | Sugiyama | CTTN EMS1 | IDDGWWRGVCKGRyGLFPANyVELRQ_______________ |
| Q14257 | Y127 | Sugiyama | RCN2 ERC55 | VEYDKNSDDTVTWDEyNIQMyDRVIDFDENtALDDAEEEsF |
| Q14257 | Y311 | Sugiyama | RCN2 ERC55 | NPDLFLtsEAtDyGRQLHDDyFyHDEL______________ |
| Q14320 | Y53 | Sugiyama | FAM50A DXS9928E HXC26 XAP5 | QRIAEENIMKSNIDKKFsAHyDAVEAELKsstVGLVtLNDM |
| Q14444 | Y99 | Sugiyama | CAPRIN1 GPIAP1 GPIP137 M11S1 RNG105 | QERMNKGERLNQDQLDAVsKyQEVtNNLEFAKELQRsFMAL |
| Q14568 | Y283 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | sDEEEEKKDGDKKKKKTKEKyIDQEELNKTKPIWTRNPDDI |
| Q14677 | Y159 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | AQDDDRLREERKKAKKNKDKyVGVssDsVGGFRysERYDPE |
| Q14966 | Y217 | Sugiyama | ZNF638 NP220 ZFML | ETLGSEAVSSNVIDYGHASKyGYTEDPLEVRIYDPEIPTDE |
| Q14974 | Y529 | Sugiyama | KPNB1 NTF97 | KLLETTDRPDGHQNNLRSSAyEsLMEIVKNSAKDCYPAVQK |
| Q14CX7 | Y19 | Sugiyama | NAA25 C12orf30 MDM20 NAP1 | __MATRGHVQDPNDRRLRPIyDyLDNGNNKMAIQQADKLLK |
| Q15021 | Y1325 | Sugiyama | NCAPD2 CAPD2 CNAP1 KIAA0159 | IGQAGsQRAPsAKKPSTGSRyQPLAstAsDNDFVtPEPRRT |
| Q15293 | Y278 | Sugiyama | RCN1 RCN | LNKDGKLDKDEIRHWILPQDyDHAQAEARHLVyESDKNKDE |
| Q15369 | Y18 | Sugiyama | ELOC TCEB1 | ___MDGEEKtyGGCEGPDAMyVKLISSDGHEFIVKREHALt |
| Q15417 | Y261 | Sugiyama | CNN3 | STISLQMGTNKVAsQKGMsVyGLGRQVYDPKYCAAPTEPVI |
| Q15459 | Y456 | Sugiyama | SF3A1 SAP114 | PRWLEQRDRSIREKQsDDEVyAPGLDIESsLKQLAERRtDI |
| Q15527 | Y123 | Sugiyama | SURF2 | GRRYQRALCKYEECQKQGVEyVPACLVHRRRRREDQMDGDG |
| Q15654 | Y123 | Sugiyama | TRIP6 OIP1 | tLAELNGGRGHASRRPDRQAyEPPPPPAyRtGsLKPNPAsP |
| Q16719 | Y441 | Sugiyama | KYNU | RGVVCDKRNPNGIRVAPVPLyNsFHDVyKFTNLLtsILDsA |
| Q16719 | Y448 | Sugiyama | KYNU | RNPNGIRVAPVPLyNsFHDVyKFTNLLtsILDsAETKN___ |
| Q3SXM5 | Y133 | Sugiyama | HSDL1 SDR12C3 | DTYKVETDIIVADFSSGREIyLPIREALKDKDVGILVNNVG |
| Q4VXU2 | Y291 | Sugiyama | PABPC1L C20orf119 | ERQNELKRRFEQMKQDRLRRyQGVNLyVKNLDDSIDDDKLR |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF6 | Y32 | Sugiyama | HSP90AB4P | KEIFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDII |
| Q58FF7 | Y56 | Sugiyama | HSP90AB3P HSP90BC | EEIFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q58FF8 | Y198 | Sugiyama | HSP90AB2P HSP90BB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKTKPIWTRNTEDI |
| Q58FF8 | Y260 | Sugiyama | HSP90AB2P HSP90BB | VRYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVW |
| Q58FF8 | Y56 | Sugiyama | HSP90AB2P HSP90BB | KEIFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDII |
| Q58FG0 | Y177 | Sugiyama | HSP90AA5P HSP90AE | GQLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQ |
| Q5JTH9 | Y1251 | Sugiyama | RRP12 KIAA0690 | AEYKAKKAKGDVKKKGRPDPyAyIPLNRSKLNRRKKMKLQG |
| Q5QNW6 | Y43 | Sugiyama | H2BC18 HIST2H2BF | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q5VTE0 | Y29 | Sugiyama | EEF1A1P5 EEF1AL3 | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| Q5VTE0 | Y86 | Sugiyama | EEF1A1P5 EEF1AL3 | ERERGITIDISLWKFEtsKyyVtIIDAPGHRDFIKNMITGT |
| Q5VV41 | Y216 | Sugiyama | ARHGEF16 EPHEXIN4 NBR | KKTLGRKRGHKGsFKDDPQLyQEIQERGLNtsQEsDDDILD |
| Q6PIW4 | Y663 | Sugiyama | FIGNL1 | DFENAFRTVRPSVSPKDLELyENWNKTFGCGK_________ |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q71U36 | Y312 | Sugiyama | TUBA1A TUBA3 | tNACFEPANQMVKCDPRHGKyMACCLLyRGDVVPKDVNAAI |
| Q7KZF4 | Y476 | Sugiyama | SND1 TDRD11 | SKGLATVIRYRQDDDQRssHyDELLAAEARAIKNGKGLHSK |
| Q86SX6 | Y88 | Sugiyama | GLRX5 C14orf87 | GFSNAVVQILRLHGVRDyAAyNVLDDPELRQGIKDYSNWPT |
| Q8IWW6 | Y243 | Sugiyama | ARHGAP12 | sTEQIRAttPPNQGRPDsPVyANLQELKISQSALPPLPGSP |
| Q8N0Y7 | S137 | Sugiyama | PGAM4 PGAM3 | RsyDVPPPPMEPDHPFysNIsKDRRYADLTEDQLPSYESPK |
| Q8N0Y7 | Y119 | Sugiyama | PGAM4 PGAM3 | NKAETAAKHGEAQVKIWRRsyDVPPPPMEPDHPFysNIsKD |
| Q8N0Y7 | Y92 | Sugiyama | PGAM4 PGAM3 | DAIDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQV |
| Q8NBS9 | Y251 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | ALGLEHSETVKIGKVDCtQHyELCsGNQVRGyPtLLWFRDG |
| Q8NI22 | Y135 | Sugiyama | MCFD2 SDNSF | DELINIIDGVLRDDDKNNDGyIDyAEFAKSLQ_________ |
| Q8TD19 | Y52 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | PSASQGPRAGGGAAEQEELHyIPIRVLGRGAFGEAtLyRRT |
| Q8WUA2 | Y363 | Sugiyama | PPIL4 | QDKPPNLVLKDKVKPKQDtKyDLILDEQAEDsKSSHSHTSK |
| Q8WX92 | Y541 | Sugiyama | NELFB COBRA1 KIAA1182 | EALQKALEPTGQSGEAVKELysQLGEKLEQLDHRKPsPAQA |
| Q8WX93 | Y1348 | Sugiyama | PALLD KIAA0992 CGI-151 | QWHQQsQstKPKKVRPSASRyAALsDQGLDIKAAFQPEANP |
| Q8WYP5 | Y1790 | Sugiyama | AHCTF1 ELYS TMBS62 MSTP108 | QSVRKKTRKAKEISEASENIySDVRGLsQNQQIPQNsVtPR |
| Q92615 | Y596 | Sugiyama | LARP4B KIAA0217 LARP5 | LPVVVSREPsVPAsCAVsAtyERsPsPAHLPDDPKVAEKQR |
| Q93052 | Y301 | Sugiyama | LPP | LQPEPGYGYAPNQGRyyEGyyAAGPGyGGRNDsDPtyGQQG |
| Q93079 | Y43 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q96AE4 | Y626 | Sugiyama | FUBP1 | GGQPDYSAAWAEYYRQQAAyyAQtsPQGMPQHPPAPQGQ__ |
| Q96QK1 | Y791 | Sugiyama | VPS35 MEM3 TCCCTA00141 | HNtLEHLRLRREsPEsEGPIyEGLIL_______________ |
| Q96RP9 | Y720 | Sugiyama | GFM1 EFG EFG1 GFM | STELRSCTEGKGEYTMEySRyQPCLPStQEDVINKYLEATG |
| Q96T37 | Y608 | Sugiyama | RBM15 OTT OTT1 | PPPPPVRERSTRTAATsVPAyEPLDSLDRRRDGWsLDRDRG |
| Q96T58 | Y116 | Sugiyama | SPEN KIAA0929 MINT SHARP | sIAsRSREVSGFRGGGGGPAyGPPPSLHAREGRYERRLDGA |
| Q99459 | Y788 | Sugiyama | CDC5L KIAA0432 PCDC5RP | ECLKEDVQRQQEREKELQHRyADLLLEKETLKSKF______ |
| Q99460 | Y494 | Sugiyama | PSMD1 | RHGGSLGLGLAAMGTARQDVyDLLKTNLYQDDAVTGEAAGL |
| Q99613 | T880 | Sugiyama | EIF3C EIF3S8 | AEKLGsLVENNERVFDHKQGtyGGyFRDQKDGYRKNEGYMR |
| Q99613 | Y881 | Sugiyama | EIF3C EIF3S8 | EKLGsLVENNERVFDHKQGtyGGyFRDQKDGYRKNEGYMRR |
| Q99733 | Y99 | Sugiyama | NAP1L4 NAP2 | HIEAKFyEEVHDLERKyAALyQPLFDKRREFItGDVEPtDA |
| Q99798 | Y71 | Sugiyama | ACO2 | NINIVRKRLNRPLTLSEKIVyGHLDDPAsQEIERGKSYLRL |
| Q99877 | Y43 | Sugiyama | H2BC15 H2BFD HIST1H2BN | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q99879 | Y43 | Sugiyama | H2BC14 H2BFE HIST1H2BM | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q99880 | Y43 | Sugiyama | H2BC13 H2BFC HIST1H2BL | QKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKAMGIM |
| Q9BQE3 | Y312 | Sugiyama | TUBA1C TUBA6 | TNACFEPANQMVKCDPRHGKyMACCLLyRGDVVPKDVNAAI |
| Q9BU89 | Y290 | Sugiyama | DOHH HLRC1 | RESCEVALDMyEHETGRAFQyADGLEQLRGAPS________ |
| Q9BWF3 | Y194 | Sugiyama | RBM4 RBM4A | ECPIDRSGRVADLTEQYNEQyGAVRTPYTMSYGDSLYYNNA |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9BZZ5 | Y28 | Sugiyama | API5 MIG8 | YRNyGILADATEQVGQHKDAyQVILDGVKGGTKEKRLAAQF |
| Q9C0C2 | Y918 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | AsQDANEQGQDLGKRDHHGRyssQDADEQDWEFQKRDVsLG |
| Q9H4M9 | Y339 | Sugiyama | EHD1 PAST PAST1 CDABP0131 | PNVFGKESKKKELVNNLGEIyQKIEREHQIsPGDFPsLRKM |
| Q9H6T3 | Y90 | Sugiyama | RPAP3 | KESSKKTREENTKNRIKsyDyEAWAKLDVDRILDELDKDDs |
| Q9H814 | Y57 | Sugiyama | PHAX RNUXA | GDsAMRAFQNTAtACAPVSHyRAVESVDSSEESFSDSDDDS |
| Q9HB07 | Y189 | Sugiyama | MYG1 C12orf10 | VEEVDAVDNGISQWAEGEPRyALttTLsARVARLNPTWNHP |
| Q9HC35 | T554 | Sugiyama | EML4 C2orf2 EMAPL4 | ILWDHDLNPEREIEVPDQyGtIRAVAEGKADQFLVGTSRNF |
| Q9NP61 | Y408 | Sugiyama | ARFGAP3 ARFGAP1 | ETVLKTTGYSDRPTARRKPDyEPVENTDEAQKKFGNVKAIs |
| Q9NRX4 | Y113 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | ysMAyGPAQHAISTEKIKAKyPDyEVtWANDGy________ |
| Q9NRX4 | Y57 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | AAESKEIVRGYKWAEyHADIyDKVSGDMQKQGCDCECLGGG |
| Q9NWS0 | Y194 | Sugiyama | PIH1D1 NOP17 | IsQQNIRSEQRPRIQELGDLytPAPGRAESGPEKPHLNLWL |
| Q9NXZ1 | Y340 | Sugiyama | SAGE1 SAGE | QPVIIYLTATGIPGMNTRDQyATITHNVCEERVVNNQPLPS |
| Q9NXZ1 | Y528 | Sugiyama | SAGE1 SAGE | APQLGHMAAGGIPSMSTKDLyATVTQNVHEERMENNQPQPS |
| Q9NZC7 | Y287 | EPSD|PSP | WWOX FOR SDR41C1 WOX1 | DINDSLGKLDFSRLSPTKNDyWAMLAYNRSKLCNILFSNEL |
| Q9P0P0 | T153 | Sugiyama | RNF181 HSPC238 | DKARKQQQQHRLENLHGAMyt____________________ |
| Q9UBR2 | Y76 | Sugiyama | CTSZ | YLSPADLPKSWDWRNVDGVNyAsItRNQHIPQYCGSCWAHA |
| Q9UBS4 | Y74 | Sugiyama | DNAJB11 EDJ ERJ3 HDJ9 PSEC0121 UNQ537/PRO1080 | PDRNPDDPQAQEKFQDLGAAyEVLsDSEKRKQyDTyGEEGL |
| Q9UHR5 | Y165 | Sugiyama | SAP30BP HCNGP HTRG HTRP | EGMDMNyIIQRKKEFRNPsIyEKLIQFCAIDELGTNYPKDM |
| Q9UI15 | Y192 | Sugiyama | TAGLN3 NP25 | NVIGLQMGSNKGAsQAGMtGyGMPRQIM_____________ |
| Q9UK59 | Y533 | Sugiyama | DBR1 | LsDEHEPEQRKKIKRRNQAIyAAVDDDDDDAA_________ |
| Q9UKS6 | Y374 | Sugiyama | PACSIN3 | sDEEsPRKAATGVRVRALyDyAGQEADELsFRAGEELLKMS |
| Q9UKY7 | Y244 | Sugiyama | CDV3 H41 | NRGRDEVSKNQALKLQLDNQyAVLENQKSSHSQYN______ |
| Q9UMX5 | Y65 | Sugiyama | NENF CIR2 SPUF | RLFtEEELARYGGEEEDQPIyLAVKGVVFDVtSGKEFYGRG |
| Q9UMY4 | Y72 | Sugiyama | SNX12 | VRMRTNLPIFKLKESCVRRRysDFEWLKNELERDSKIVVPP |
| Q9UN86 | Y20 | Sugiyama | G3BP2 KIAA0660 | _MVMEKPsPLLVGREFVRQyytLLNKAPEYLHRFYGRNSSY |
| Q9UQ35 | S846 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | KSKtPsRQsHSsssPHPKVKsGtPPRQGsItsPQANEQsVt |
| Q9Y262 | Y45 | Sugiyama | EIF3L EIF3EIP EIF3S6IP HSPC021 HSPC025 MSTP005 | MHTGDPKQDLAyERQyEQQtyQVIPEVIKNFIQYFHKTVSD |
| Q9Y281 | Y82 | Sugiyama | CFL2 | DTVEDPYtsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFI |
| Q9Y281 | Y85 | Sugiyama | CFL2 | EDPYtsFVKLLPLNDCRyALyDAtyEtKESKKEDLVFIFWA |
| Q9Y2T7 | Y107 | Sugiyama | YBX2 CSDA3 MSY2 | KPVLAIQVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| Q9Y3D8 | Y31 | Sugiyama | AK6 CINAP AD-004 CGI-137 | TPGVGKTTLGKELASKSGLKyINVGDLAREEQLYDGYDEEY |
| Q9Y3F4 | Y300 | Sugiyama | STRAP MAWD UNRIP | yAsGSEDGTLRLWQTVVGKtyGLWKCVLPEEDsGELAKPKI |
| Q9Y3P9 | Y472 | Sugiyama | RABGAP1 HSPC094 | FFLKLKQIKQRERKNNTDTLyEVVCLESESERERRKTTAsP |
| Q9Y4C1 | Y1114 | SIGNOR|EPSD|PSP | KDM3A JHDM2A JMJD1 JMJD1A KIAA0742 TSGA | PDLGPKMyNAYGLITPEDRKyGTTNLHLDVSDAANVMVYVG |
| Q9Y4H2 | S805 | Sugiyama | IRS2 | sAALHPGGEPLRGVPGCCyssLPRSYKAPytCGGDsDQyVL |
| Q9Y4L1 | Y759 | Sugiyama | HYOU1 GRP170 HSPH4 ORP150 | AANsLEAFIFEtQDKLyQPEyQEVsTEEQREEISGKLSAAS |
| Q9Y5P6 | Y144 | Sugiyama | GMPPB | HRHHGQEGSILVTKVEEPSKyGVVVCEADTGRIHRFVEKPQ |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
| Q9Y5S9 | Y54 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KRKGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWI |
| Q9Y639 | Y220 | Sugiyama | NPTN SDFR1 SDR1 | NMEYRINKPRAEDsGEyHCVyHFVsAPKANATIEVKAAPDI |
| Q9Y6N7 | Y1114 | Sugiyama | ROBO1 DUTT1 | sGEKHWKPLGQQKQEVAPVQyNIVEQNKLNKDYRANDTVPP |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 9.375005e-10 | 9.028 | 1 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 6.932872e-09 | 8.159 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 6.420912e-08 | 7.192 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.717782e-06 | 5.765 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 2.231805e-06 | 5.651 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.021451e-06 | 5.991 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 2.465530e-06 | 5.608 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.894149e-06 | 5.538 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 5.107680e-06 | 5.292 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 5.635400e-06 | 5.249 | 1 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.291516e-05 | 4.889 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.291516e-05 | 4.889 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.411249e-05 | 4.850 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 1.829084e-05 | 4.738 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 2.923863e-05 | 4.534 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 4.713291e-05 | 4.327 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 6.935448e-05 | 4.159 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.360857e-05 | 4.078 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 8.199238e-05 | 4.086 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 9.988138e-05 | 4.001 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 1.183386e-04 | 3.927 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.235525e-04 | 3.908 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.430551e-04 | 3.844 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 2.395278e-04 | 3.621 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 2.491549e-04 | 3.604 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.707560e-04 | 3.567 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 3.075795e-04 | 3.512 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 3.075795e-04 | 3.512 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 3.075795e-04 | 3.512 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 3.656562e-04 | 3.437 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 5.172112e-04 | 3.286 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 6.174626e-04 | 3.209 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 6.211480e-04 | 3.207 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 6.114359e-04 | 3.214 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.125726e-03 | 2.949 | 0 | 0 |
| Signaling by FGFR1 amplification mutants | R-HSA-1839120 | 1.353256e-03 | 2.869 | 0 | 0 |
| TRKA activation by NGF | R-HSA-187042 | 1.353256e-03 | 2.869 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.342492e-03 | 2.872 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 1.353256e-03 | 2.869 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.407264e-03 | 2.852 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.417793e-03 | 2.848 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 1.542109e-03 | 2.812 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 1.541206e-03 | 2.812 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 1.541206e-03 | 2.812 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.694570e-03 | 2.771 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 1.622345e-03 | 2.790 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.694570e-03 | 2.771 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.759391e-03 | 2.755 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.759391e-03 | 2.755 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.935164e-03 | 2.713 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.935164e-03 | 2.713 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.969490e-03 | 2.706 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.994879e-03 | 2.700 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.141495e-03 | 2.669 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.249092e-03 | 2.648 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.838905e-03 | 2.547 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 3.173318e-03 | 2.498 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 3.462792e-03 | 2.461 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 3.378483e-03 | 2.471 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 3.592496e-03 | 2.445 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 3.392763e-03 | 2.469 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 3.817642e-03 | 2.418 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 4.591867e-03 | 2.338 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 5.228077e-03 | 2.282 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 5.228077e-03 | 2.282 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 4.801477e-03 | 2.319 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 4.922250e-03 | 2.308 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 5.310089e-03 | 2.275 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 5.353107e-03 | 2.271 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 5.647288e-03 | 2.248 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 6.580266e-03 | 2.182 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 6.713887e-03 | 2.173 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 6.919892e-03 | 2.160 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 7.258305e-03 | 2.139 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 7.258305e-03 | 2.139 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 7.424773e-03 | 2.129 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 7.424773e-03 | 2.129 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 8.359304e-03 | 2.078 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 8.597633e-03 | 2.066 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 8.597633e-03 | 2.066 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 8.597633e-03 | 2.066 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.613967e-03 | 2.118 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.980920e-03 | 2.098 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 7.774018e-03 | 2.109 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.613967e-03 | 2.118 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 1.136293e-02 | 1.945 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 1.136293e-02 | 1.945 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.133942e-02 | 1.945 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 1.049402e-02 | 1.979 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 9.837262e-03 | 2.007 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.837262e-03 | 2.007 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 1.117564e-02 | 1.952 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.019046e-02 | 1.992 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 1.117564e-02 | 1.952 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.158082e-02 | 1.936 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 1.181402e-02 | 1.928 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 1.227417e-02 | 1.911 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.230121e-02 | 1.910 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.283952e-02 | 1.891 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.371082e-02 | 1.863 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.387123e-02 | 1.858 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.439495e-02 | 1.842 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.496177e-02 | 1.825 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.773513e-02 | 1.751 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.845079e-02 | 1.734 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.753987e-02 | 1.756 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.788832e-02 | 1.747 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.845079e-02 | 1.734 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.845079e-02 | 1.734 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.726962e-02 | 1.763 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.579543e-02 | 1.801 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.773513e-02 | 1.751 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.665477e-02 | 1.778 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 1.595852e-02 | 1.797 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.605731e-02 | 1.794 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.938758e-02 | 1.712 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.050038e-02 | 1.688 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.105024e-02 | 1.677 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.133885e-02 | 1.671 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.136933e-02 | 1.670 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.156165e-02 | 1.666 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.188982e-02 | 1.660 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 2.329239e-02 | 1.633 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.329239e-02 | 1.633 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.135819e-02 | 1.504 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5619101 | 3.135819e-02 | 1.504 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.135819e-02 | 1.504 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5660686 | 3.135819e-02 | 1.504 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.135819e-02 | 1.504 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.528387e-02 | 1.597 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 2.528387e-02 | 1.597 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.528387e-02 | 1.597 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 2.946550e-02 | 1.531 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.946550e-02 | 1.531 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 3.135819e-02 | 1.504 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 3.135819e-02 | 1.504 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.946550e-02 | 1.531 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.801535e-02 | 1.553 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 2.528387e-02 | 1.597 | 0 | 0 |
| Immune System | R-HSA-168256 | 2.665967e-02 | 1.574 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 2.952770e-02 | 1.530 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.140179e-02 | 1.503 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 3.140179e-02 | 1.503 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 3.140179e-02 | 1.503 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 3.165246e-02 | 1.500 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.297790e-02 | 1.482 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.506694e-02 | 1.455 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 3.543012e-02 | 1.451 | 0 | 0 |
| Kinesins | R-HSA-983189 | 3.654287e-02 | 1.437 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.159212e-02 | 1.381 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.159212e-02 | 1.381 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.159212e-02 | 1.381 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.159212e-02 | 1.381 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.159212e-02 | 1.381 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.159212e-02 | 1.381 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.159212e-02 | 1.381 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.159212e-02 | 1.381 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.159212e-02 | 1.381 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.159212e-02 | 1.381 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.159212e-02 | 1.381 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 3.857921e-02 | 1.414 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 4.100505e-02 | 1.387 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 4.100505e-02 | 1.387 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 4.100505e-02 | 1.387 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 4.861283e-02 | 1.313 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 4.861283e-02 | 1.313 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 4.957864e-02 | 1.305 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 4.412396e-02 | 1.355 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 3.845459e-02 | 1.415 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 4.861283e-02 | 1.313 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.894485e-02 | 1.410 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.602328e-02 | 1.337 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.894485e-02 | 1.410 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.405208e-02 | 1.356 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 4.376700e-02 | 1.359 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 5.125413e-02 | 1.290 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 5.125413e-02 | 1.290 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 5.171856e-02 | 1.286 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 5.171856e-02 | 1.286 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 5.171856e-02 | 1.286 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 5.171856e-02 | 1.286 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 5.394583e-02 | 1.268 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.394583e-02 | 1.268 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 5.437366e-02 | 1.265 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 5.600615e-02 | 1.252 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.668656e-02 | 1.247 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.668656e-02 | 1.247 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 5.759682e-02 | 1.240 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 5.947502e-02 | 1.226 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 5.947502e-02 | 1.226 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 5.947502e-02 | 1.226 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 6.173862e-02 | 1.209 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 6.173862e-02 | 1.209 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 6.173862e-02 | 1.209 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 6.173862e-02 | 1.209 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 6.173862e-02 | 1.209 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 6.173862e-02 | 1.209 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 6.230990e-02 | 1.205 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 6.518991e-02 | 1.186 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 6.714450e-02 | 1.173 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 6.815196e-02 | 1.167 | 0 | 0 |
| FGFR1c and Klotho ligand binding and activation | R-HSA-190374 | 7.165341e-02 | 1.145 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 8.146404e-02 | 1.089 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 8.146404e-02 | 1.089 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 8.146404e-02 | 1.089 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 8.146404e-02 | 1.089 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 8.146404e-02 | 1.089 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 9.117159e-02 | 1.040 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 8.334906e-02 | 1.079 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 8.146404e-02 | 1.089 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 7.165341e-02 | 1.145 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 7.165341e-02 | 1.145 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 7.408835e-02 | 1.130 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 8.146404e-02 | 1.089 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 8.146404e-02 | 1.089 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 8.146404e-02 | 1.089 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 8.146404e-02 | 1.089 | 0 | 0 |
| Reuptake of GABA | R-HSA-888593 | 1.007771e-01 | 0.997 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 9.563416e-02 | 1.019 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 9.117159e-02 | 1.040 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 1.061941e-01 | 0.974 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 8.970868e-02 | 1.047 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 7.165341e-02 | 1.145 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.015147e-01 | 0.993 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 8.146404e-02 | 1.089 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 7.538870e-02 | 1.123 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.620659e-02 | 1.017 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 7.466505e-02 | 1.127 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 7.217907e-02 | 1.142 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 8.651104e-02 | 1.063 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 8.540189e-02 | 1.069 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 9.311721e-02 | 1.031 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.001433e-01 | 0.999 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 9.294089e-02 | 1.032 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.061941e-01 | 0.974 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.063916e-01 | 0.973 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 1.102818e-01 | 0.957 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.102818e-01 | 0.957 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 1.102818e-01 | 0.957 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 1.102818e-01 | 0.957 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 1.102818e-01 | 0.957 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 1.102818e-01 | 0.957 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.102818e-01 | 0.957 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.108222e-01 | 0.955 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.119683e-01 | 0.951 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.130010e-01 | 0.947 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.130010e-01 | 0.947 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.164461e-01 | 0.934 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.175989e-01 | 0.930 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.196865e-01 | 0.922 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.196865e-01 | 0.922 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 1.196865e-01 | 0.922 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 1.196865e-01 | 0.922 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.199176e-01 | 0.921 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.199176e-01 | 0.921 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.289924e-01 | 0.889 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 1.289924e-01 | 0.889 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.289924e-01 | 0.889 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.563273e-01 | 0.806 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 1.740751e-01 | 0.759 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 1.828093e-01 | 0.738 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.914516e-01 | 0.718 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.000031e-01 | 0.699 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 2.333192e-01 | 0.632 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.494563e-01 | 0.603 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.494563e-01 | 0.603 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.340499e-01 | 0.873 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.414304e-01 | 0.617 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.414304e-01 | 0.617 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.084647e-01 | 0.681 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.084647e-01 | 0.681 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.333192e-01 | 0.632 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 2.251218e-01 | 0.648 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 2.333192e-01 | 0.632 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.289924e-01 | 0.889 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.289924e-01 | 0.889 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 2.494563e-01 | 0.603 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 1.563273e-01 | 0.806 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 1.563273e-01 | 0.806 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.652481e-01 | 0.782 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 1.652481e-01 | 0.782 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 2.414304e-01 | 0.617 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 1.652481e-01 | 0.782 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.494563e-01 | 0.603 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 2.251218e-01 | 0.648 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.485336e-01 | 0.828 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.289924e-01 | 0.889 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 1.289924e-01 | 0.889 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.382005e-01 | 0.859 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.563273e-01 | 0.806 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.670520e-01 | 0.777 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.449454e-01 | 0.611 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.740751e-01 | 0.759 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 1.586614e-01 | 0.800 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.400901e-01 | 0.620 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 1.899177e-01 | 0.721 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.479111e-01 | 0.606 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.740751e-01 | 0.759 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.828093e-01 | 0.738 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.251218e-01 | 0.648 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.898187e-01 | 0.722 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 2.000031e-01 | 0.699 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.251218e-01 | 0.648 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 2.333192e-01 | 0.632 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.834595e-01 | 0.736 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 1.828093e-01 | 0.738 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 2.414304e-01 | 0.617 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 2.494563e-01 | 0.603 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.708030e-01 | 0.768 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 2.494563e-01 | 0.603 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 1.708030e-01 | 0.768 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.494563e-01 | 0.603 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.089749e-01 | 0.680 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.400901e-01 | 0.620 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 2.115028e-01 | 0.675 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.563273e-01 | 0.806 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.382005e-01 | 0.859 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 1.382005e-01 | 0.859 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.828093e-01 | 0.738 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 1.828093e-01 | 0.738 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 1.914516e-01 | 0.718 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.400901e-01 | 0.620 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.728908e-01 | 0.762 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.750947e-01 | 0.757 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.792605e-01 | 0.747 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.382005e-01 | 0.859 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 1.382005e-01 | 0.859 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.828093e-01 | 0.738 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.485336e-01 | 0.828 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 1.841186e-01 | 0.735 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 1.363911e-01 | 0.865 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.987033e-01 | 0.702 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 1.783467e-01 | 0.749 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.419579e-01 | 0.848 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 1.914516e-01 | 0.718 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 1.914516e-01 | 0.718 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.225821e-01 | 0.653 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.652481e-01 | 0.782 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.740751e-01 | 0.759 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.494563e-01 | 0.603 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.333192e-01 | 0.632 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.766237e-01 | 0.753 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 2.051135e-01 | 0.688 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.322817e-01 | 0.634 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 2.322817e-01 | 0.634 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.236457e-01 | 0.650 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 1.708030e-01 | 0.768 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.128438e-01 | 0.672 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 2.494563e-01 | 0.603 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 1.382005e-01 | 0.859 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.750947e-01 | 0.757 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 2.093027e-01 | 0.679 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 2.206021e-01 | 0.656 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.821378e-01 | 0.740 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.400901e-01 | 0.620 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.244902e-01 | 0.649 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 2.573977e-01 | 0.589 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 2.573977e-01 | 0.589 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 2.573977e-01 | 0.589 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 2.573977e-01 | 0.589 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 2.647961e-01 | 0.577 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.647961e-01 | 0.577 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 2.652557e-01 | 0.576 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 2.652557e-01 | 0.576 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.652557e-01 | 0.576 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 2.699344e-01 | 0.569 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 2.705057e-01 | 0.568 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 2.714116e-01 | 0.566 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.714116e-01 | 0.566 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 2.730309e-01 | 0.564 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 2.730309e-01 | 0.564 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.730309e-01 | 0.564 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.730309e-01 | 0.564 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 2.751672e-01 | 0.560 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.753290e-01 | 0.560 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 2.807243e-01 | 0.552 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.807243e-01 | 0.552 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 2.807243e-01 | 0.552 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 2.807243e-01 | 0.552 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.865794e-01 | 0.543 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.870737e-01 | 0.542 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 2.883368e-01 | 0.540 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.883368e-01 | 0.540 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 2.883368e-01 | 0.540 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 2.883368e-01 | 0.540 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 2.883368e-01 | 0.540 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 2.918485e-01 | 0.535 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.947640e-01 | 0.531 | 0 | 0 |
| Protein folding | R-HSA-391251 | 2.948932e-01 | 0.530 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 2.958692e-01 | 0.529 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 2.958692e-01 | 0.529 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 2.958692e-01 | 0.529 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 2.958692e-01 | 0.529 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 2.958692e-01 | 0.529 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 2.958692e-01 | 0.529 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 2.958692e-01 | 0.529 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.958692e-01 | 0.529 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 2.987987e-01 | 0.525 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 2.987987e-01 | 0.525 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 3.027008e-01 | 0.519 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 3.033223e-01 | 0.518 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 3.033223e-01 | 0.518 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 3.033223e-01 | 0.518 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 3.033223e-01 | 0.518 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 3.106970e-01 | 0.508 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 3.106970e-01 | 0.508 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 3.106970e-01 | 0.508 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 3.106970e-01 | 0.508 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 3.179941e-01 | 0.498 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 3.179941e-01 | 0.498 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 3.252144e-01 | 0.488 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.260240e-01 | 0.487 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 3.298931e-01 | 0.482 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 3.323587e-01 | 0.478 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.323587e-01 | 0.478 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 3.339046e-01 | 0.476 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 3.339046e-01 | 0.476 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.376129e-01 | 0.472 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.376129e-01 | 0.472 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 3.394277e-01 | 0.469 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.394277e-01 | 0.469 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 3.394277e-01 | 0.469 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.394277e-01 | 0.469 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 3.394277e-01 | 0.469 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.394277e-01 | 0.469 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.396852e-01 | 0.469 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.453062e-01 | 0.462 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.464224e-01 | 0.460 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 3.464224e-01 | 0.460 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 3.464224e-01 | 0.460 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 3.533434e-01 | 0.452 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 3.563417e-01 | 0.448 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 3.601916e-01 | 0.443 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.644088e-01 | 0.438 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.669676e-01 | 0.435 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.669676e-01 | 0.435 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.682048e-01 | 0.434 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 3.736724e-01 | 0.428 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.736724e-01 | 0.428 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 3.736724e-01 | 0.428 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 3.736724e-01 | 0.428 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.736724e-01 | 0.428 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 3.736724e-01 | 0.428 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 3.795393e-01 | 0.421 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 3.803065e-01 | 0.420 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.868707e-01 | 0.412 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.868707e-01 | 0.412 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.868707e-01 | 0.412 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.868707e-01 | 0.412 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 3.922994e-01 | 0.406 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 3.933658e-01 | 0.405 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.933658e-01 | 0.405 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.933658e-01 | 0.405 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 3.933658e-01 | 0.405 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 3.982382e-01 | 0.400 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 3.997925e-01 | 0.398 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.997925e-01 | 0.398 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 3.999824e-01 | 0.398 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 4.061515e-01 | 0.391 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 4.061515e-01 | 0.391 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 4.061515e-01 | 0.391 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 4.061515e-01 | 0.391 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 4.061515e-01 | 0.391 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 4.061515e-01 | 0.391 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.124436e-01 | 0.385 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 4.124436e-01 | 0.385 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.124436e-01 | 0.385 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 4.186693e-01 | 0.378 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 4.186693e-01 | 0.378 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 4.186693e-01 | 0.378 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.203286e-01 | 0.376 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 4.203286e-01 | 0.376 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.248295e-01 | 0.372 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 4.254071e-01 | 0.371 | 0 | 0 |
| M Phase | R-HSA-68886 | 4.262794e-01 | 0.370 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 4.309248e-01 | 0.366 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.309248e-01 | 0.366 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.309248e-01 | 0.366 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 4.318184e-01 | 0.365 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.369558e-01 | 0.360 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 4.369558e-01 | 0.360 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 4.369558e-01 | 0.360 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 4.369558e-01 | 0.360 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 4.369558e-01 | 0.360 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 4.369558e-01 | 0.360 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.429233e-01 | 0.354 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 4.455718e-01 | 0.351 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 4.466114e-01 | 0.350 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 4.476948e-01 | 0.349 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 4.504574e-01 | 0.346 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 4.587114e-01 | 0.338 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 4.604511e-01 | 0.337 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 4.604511e-01 | 0.337 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 4.614513e-01 | 0.336 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 4.641853e-01 | 0.333 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 4.701966e-01 | 0.328 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 4.718307e-01 | 0.326 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 4.718307e-01 | 0.326 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.774306e-01 | 0.321 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 4.774306e-01 | 0.321 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.774306e-01 | 0.321 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 4.774306e-01 | 0.321 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 4.873841e-01 | 0.312 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.884541e-01 | 0.311 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 4.907801e-01 | 0.309 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 4.911835e-01 | 0.309 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 4.938475e-01 | 0.306 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 4.938788e-01 | 0.306 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 4.938788e-01 | 0.306 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 4.938788e-01 | 0.306 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.941620e-01 | 0.306 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 4.992463e-01 | 0.302 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 5.008834e-01 | 0.300 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 5.098121e-01 | 0.293 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 5.098121e-01 | 0.293 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 5.098121e-01 | 0.293 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 5.098121e-01 | 0.293 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 5.128605e-01 | 0.290 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 5.150117e-01 | 0.288 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 5.150117e-01 | 0.288 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 5.201563e-01 | 0.284 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 5.201563e-01 | 0.284 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 5.201563e-01 | 0.284 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 5.201563e-01 | 0.284 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 5.207024e-01 | 0.283 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.252468e-01 | 0.280 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 5.252468e-01 | 0.280 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.252468e-01 | 0.280 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 5.271919e-01 | 0.278 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 5.302835e-01 | 0.275 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 5.304145e-01 | 0.275 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 5.352671e-01 | 0.271 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 5.399930e-01 | 0.268 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 5.401981e-01 | 0.267 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 5.450772e-01 | 0.264 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 5.463039e-01 | 0.263 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 5.481160e-01 | 0.261 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 5.482001e-01 | 0.261 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.499047e-01 | 0.260 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 5.499047e-01 | 0.260 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 5.499047e-01 | 0.260 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 5.506157e-01 | 0.259 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 5.525545e-01 | 0.258 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 5.525633e-01 | 0.258 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.546813e-01 | 0.256 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 5.546813e-01 | 0.256 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 5.587447e-01 | 0.253 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.640839e-01 | 0.249 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 5.640839e-01 | 0.249 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 5.640839e-01 | 0.249 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 5.687109e-01 | 0.245 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 5.687109e-01 | 0.245 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 5.687109e-01 | 0.245 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 5.687109e-01 | 0.245 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 5.687109e-01 | 0.245 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.732890e-01 | 0.242 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 5.769501e-01 | 0.239 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 5.778189e-01 | 0.238 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.823009e-01 | 0.235 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 5.911236e-01 | 0.228 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 5.974936e-01 | 0.224 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 5.997610e-01 | 0.222 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.997610e-01 | 0.222 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 5.997610e-01 | 0.222 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.040114e-01 | 0.219 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 6.060677e-01 | 0.217 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 6.060677e-01 | 0.217 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 6.060677e-01 | 0.217 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.082169e-01 | 0.216 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 6.116785e-01 | 0.213 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 6.123781e-01 | 0.213 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 6.149398e-01 | 0.211 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.164953e-01 | 0.210 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 6.205690e-01 | 0.207 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 6.285878e-01 | 0.202 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 6.285878e-01 | 0.202 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.285878e-01 | 0.202 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.325338e-01 | 0.199 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.364381e-01 | 0.196 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 6.441235e-01 | 0.191 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 6.449580e-01 | 0.190 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 6.468724e-01 | 0.189 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 6.516473e-01 | 0.186 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 6.516473e-01 | 0.186 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 6.543194e-01 | 0.184 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 6.546229e-01 | 0.184 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.553497e-01 | 0.184 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 6.571763e-01 | 0.182 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 6.622382e-01 | 0.179 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 6.626375e-01 | 0.179 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 6.672402e-01 | 0.176 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 6.686979e-01 | 0.175 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 6.767567e-01 | 0.170 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 6.770660e-01 | 0.169 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 6.801937e-01 | 0.167 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 6.801937e-01 | 0.167 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 6.835944e-01 | 0.165 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 6.835944e-01 | 0.165 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.869591e-01 | 0.163 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.869591e-01 | 0.163 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.869591e-01 | 0.163 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 6.869591e-01 | 0.163 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 6.947250e-01 | 0.158 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 7.000660e-01 | 0.155 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 7.064134e-01 | 0.151 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 7.095368e-01 | 0.149 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 7.095368e-01 | 0.149 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 7.095368e-01 | 0.149 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.126272e-01 | 0.147 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 7.156849e-01 | 0.145 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 7.187102e-01 | 0.143 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 7.196982e-01 | 0.143 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.217036e-01 | 0.142 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 7.233831e-01 | 0.141 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 7.246653e-01 | 0.140 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 7.269640e-01 | 0.138 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.275956e-01 | 0.138 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.275956e-01 | 0.138 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 7.304949e-01 | 0.136 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.333636e-01 | 0.135 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.333636e-01 | 0.135 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 7.362019e-01 | 0.133 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 7.362019e-01 | 0.133 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 7.373582e-01 | 0.132 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.445378e-01 | 0.128 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 7.445378e-01 | 0.128 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 7.454305e-01 | 0.128 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 7.493868e-01 | 0.125 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.526118e-01 | 0.123 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.526118e-01 | 0.123 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 7.532906e-01 | 0.123 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 7.578530e-01 | 0.120 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 7.578530e-01 | 0.120 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 7.611820e-01 | 0.119 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 7.646907e-01 | 0.117 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.655085e-01 | 0.116 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.655085e-01 | 0.116 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 7.680065e-01 | 0.115 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 7.704781e-01 | 0.113 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 7.753429e-01 | 0.111 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 7.753429e-01 | 0.111 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 7.753429e-01 | 0.111 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 7.753429e-01 | 0.111 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 7.765932e-01 | 0.110 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 7.809377e-01 | 0.107 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 7.893307e-01 | 0.103 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 7.912188e-01 | 0.102 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.915763e-01 | 0.102 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 7.915763e-01 | 0.102 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 7.923410e-01 | 0.101 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 7.937981e-01 | 0.100 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 7.937981e-01 | 0.100 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 8.045589e-01 | 0.094 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 8.087187e-01 | 0.092 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.120528e-01 | 0.090 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 8.186923e-01 | 0.087 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 8.281609e-01 | 0.082 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.299948e-01 | 0.081 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.324082e-01 | 0.080 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 8.336043e-01 | 0.079 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 8.353805e-01 | 0.078 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.371377e-01 | 0.077 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.388763e-01 | 0.076 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 8.388763e-01 | 0.076 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 8.405358e-01 | 0.075 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 8.405965e-01 | 0.075 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.422984e-01 | 0.075 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 8.456482e-01 | 0.073 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.456482e-01 | 0.073 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 8.495167e-01 | 0.071 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 8.505407e-01 | 0.070 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 8.505407e-01 | 0.070 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 8.613653e-01 | 0.065 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.613653e-01 | 0.065 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.686164e-01 | 0.061 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 8.700207e-01 | 0.060 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 8.741448e-01 | 0.058 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 8.781387e-01 | 0.056 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 8.807311e-01 | 0.055 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 8.811105e-01 | 0.055 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 8.845172e-01 | 0.053 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 8.889490e-01 | 0.051 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 8.912299e-01 | 0.050 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 8.980768e-01 | 0.047 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 9.068785e-01 | 0.042 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.108046e-01 | 0.041 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.216225e-01 | 0.035 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 9.288704e-01 | 0.032 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.299375e-01 | 0.032 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 9.299375e-01 | 0.032 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.381073e-01 | 0.028 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.426785e-01 | 0.026 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.589987e-01 | 0.018 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.632999e-01 | 0.016 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 9.669811e-01 | 0.015 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 9.831541e-01 | 0.007 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.872060e-01 | 0.006 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.971958e-01 | 0.001 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.995879e-01 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.999859e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.999914e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.110223e-16 | 15.955 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.110223e-16 | 15.955 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.110223e-16 | 15.955 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.110223e-16 | 15.955 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.110223e-16 | 15.955 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.110223e-16 | 15.955 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 2.112754e-13 | 12.675 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.982059e-13 | 12.525 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.076739e-13 | 12.390 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 5.838663e-13 | 12.234 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 5.838663e-13 | 12.234 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 8.061329e-13 | 12.094 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 8.932854e-13 | 12.049 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.017741e-12 | 11.992 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.092237e-12 | 11.962 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.108114e-12 | 11.955 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.916245e-12 | 11.718 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 2.614908e-12 | 11.583 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 3.443357e-12 | 11.463 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 3.376521e-12 | 11.472 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 5.844547e-12 | 11.233 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 5.844547e-12 | 11.233 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 7.370438e-12 | 11.133 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.663714e-12 | 11.015 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.000278e-11 | 11.000 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.231404e-11 | 10.910 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.231404e-11 | 10.910 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.286571e-11 | 10.891 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.560230e-11 | 10.807 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.899536e-11 | 10.721 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.184042e-11 | 10.661 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.184042e-11 | 10.661 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.250045e-11 | 10.648 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.464851e-11 | 10.608 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 2.740697e-11 | 10.562 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 3.074663e-11 | 10.512 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 3.074663e-11 | 10.512 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 3.939948e-11 | 10.405 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 4.020217e-11 | 10.396 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 4.020217e-11 | 10.396 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 4.717104e-11 | 10.326 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 4.717104e-11 | 10.326 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 5.078715e-11 | 10.294 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.332590e-11 | 10.273 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 5.803735e-11 | 10.236 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 7.110557e-11 | 10.148 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 7.470702e-11 | 10.127 | 0 | 0 |
| Immune System | R-HSA-168256 | 7.783296e-11 | 10.109 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 8.676260e-11 | 10.062 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 8.676260e-11 | 10.062 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.035798e-10 | 9.985 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.054534e-10 | 9.977 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.276880e-10 | 9.894 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.222045e-10 | 9.913 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.540494e-10 | 9.812 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.623190e-10 | 9.790 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.929561e-10 | 9.715 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.852024e-10 | 9.732 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.908824e-10 | 9.719 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.230144e-10 | 9.652 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.418545e-10 | 9.616 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 2.650079e-10 | 9.577 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 3.154875e-10 | 9.501 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 3.327315e-10 | 9.478 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 4.021834e-10 | 9.396 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 4.430890e-10 | 9.354 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 4.628087e-10 | 9.335 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 5.002379e-10 | 9.301 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 5.228301e-10 | 9.282 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 9.866588e-10 | 9.006 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.182576e-09 | 8.927 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.149145e-09 | 8.940 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.372482e-09 | 8.862 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.547822e-09 | 8.810 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.547822e-09 | 8.810 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.711832e-09 | 8.767 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.813148e-09 | 8.742 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.862823e-09 | 8.730 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.069880e-09 | 8.684 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.458196e-09 | 8.609 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 2.428571e-09 | 8.615 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.734792e-09 | 8.563 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 2.861449e-09 | 8.543 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 3.136771e-09 | 8.504 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.590807e-09 | 8.445 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 3.761439e-09 | 8.425 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 4.678976e-09 | 8.330 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 5.182999e-09 | 8.285 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 5.182999e-09 | 8.285 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.182999e-09 | 8.285 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 4.676944e-09 | 8.330 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 4.678976e-09 | 8.330 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 5.326503e-09 | 8.274 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 5.859188e-09 | 8.232 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 6.627957e-09 | 8.179 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 6.825245e-09 | 8.166 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 7.580072e-09 | 8.120 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 8.558232e-09 | 8.068 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 9.926314e-09 | 8.003 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.259124e-08 | 7.900 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.262600e-08 | 7.899 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.309397e-08 | 7.883 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.587687e-08 | 7.799 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.540786e-08 | 7.812 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.613292e-08 | 7.792 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.779020e-08 | 7.750 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.779020e-08 | 7.750 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.061796e-08 | 7.686 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.061796e-08 | 7.686 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.482351e-08 | 7.605 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 2.735744e-08 | 7.563 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 2.735744e-08 | 7.563 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 3.478673e-08 | 7.459 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 4.215666e-08 | 7.375 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 5.166984e-08 | 7.287 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 5.710664e-08 | 7.243 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.882071e-08 | 7.230 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 7.056888e-08 | 7.151 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 7.225818e-08 | 7.141 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 7.659614e-08 | 7.116 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 9.028391e-08 | 7.044 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.086475e-07 | 6.964 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.277919e-07 | 6.893 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.382540e-07 | 6.859 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.415425e-07 | 6.849 | 1 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.424835e-07 | 6.846 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.723871e-07 | 6.763 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.109640e-07 | 6.676 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.931593e-07 | 6.533 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.931593e-07 | 6.533 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.940438e-07 | 6.532 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 3.152150e-07 | 6.501 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.728442e-07 | 6.428 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 3.784729e-07 | 6.422 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 3.784729e-07 | 6.422 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 3.818000e-07 | 6.418 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 4.123848e-07 | 6.385 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 4.698613e-07 | 6.328 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 5.112795e-07 | 6.291 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 5.522867e-07 | 6.258 | 0 | 0 |
| Protein folding | R-HSA-391251 | 6.517278e-07 | 6.186 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 6.517278e-07 | 6.186 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 7.051224e-07 | 6.152 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 7.168005e-07 | 6.145 | 0 | 0 |
| Disease | R-HSA-1643685 | 7.556192e-07 | 6.122 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 7.769068e-07 | 6.110 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 8.648670e-07 | 6.063 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 9.905489e-07 | 6.004 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.053907e-06 | 5.977 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 9.981442e-07 | 6.001 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 9.981442e-07 | 6.001 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 8.650619e-07 | 6.063 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.054998e-06 | 5.977 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.054998e-06 | 5.977 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.054998e-06 | 5.977 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.172104e-06 | 5.931 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.519421e-06 | 5.818 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.519421e-06 | 5.818 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.519421e-06 | 5.818 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.522728e-06 | 5.817 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.617694e-06 | 5.791 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.426584e-06 | 5.615 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.948856e-06 | 5.530 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 3.201886e-06 | 5.495 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 3.486409e-06 | 5.458 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.558989e-06 | 5.449 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 3.639213e-06 | 5.439 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 3.870235e-06 | 5.412 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 3.917077e-06 | 5.407 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 4.365430e-06 | 5.360 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 4.632153e-06 | 5.334 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.758740e-06 | 5.323 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 4.933222e-06 | 5.307 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 5.197300e-06 | 5.284 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 5.473734e-06 | 5.262 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 5.763015e-06 | 5.239 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 6.238335e-06 | 5.205 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 6.783333e-06 | 5.169 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 6.859732e-06 | 5.164 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 7.123793e-06 | 5.147 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 7.385778e-06 | 5.132 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 7.420499e-06 | 5.130 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 7.614258e-06 | 5.118 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 8.638266e-06 | 5.064 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 9.027383e-06 | 5.044 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 9.908998e-06 | 5.004 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.908998e-06 | 5.004 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.008668e-05 | 4.996 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.045523e-05 | 4.981 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.074891e-05 | 4.969 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.667156e-05 | 4.778 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.609988e-05 | 4.793 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.740087e-05 | 4.759 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.776358e-05 | 4.750 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.227603e-05 | 4.652 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 2.764610e-05 | 4.558 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 3.307045e-05 | 4.481 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.462525e-05 | 4.461 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 3.532099e-05 | 4.452 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 3.893889e-05 | 4.410 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 4.191691e-05 | 4.378 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 5.767103e-05 | 4.239 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 6.017945e-05 | 4.221 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 6.017945e-05 | 4.221 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 6.017945e-05 | 4.221 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 6.017945e-05 | 4.221 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 6.452573e-05 | 4.190 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 6.721804e-05 | 4.173 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 7.336875e-05 | 4.134 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 8.925484e-05 | 4.049 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 9.250316e-05 | 4.034 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 9.646726e-05 | 4.016 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 9.646726e-05 | 4.016 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.863554e-05 | 4.006 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 1.517948e-04 | 3.819 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 1.517948e-04 | 3.819 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 1.517948e-04 | 3.819 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.639967e-04 | 3.785 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.736396e-04 | 3.760 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.800157e-04 | 3.745 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 1.987734e-04 | 3.702 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.990219e-04 | 3.701 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.994483e-04 | 3.700 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 2.169342e-04 | 3.664 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.262624e-04 | 3.645 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.643274e-04 | 3.578 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 2.652429e-04 | 3.576 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 2.959704e-04 | 3.529 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.037239e-04 | 3.518 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.361841e-04 | 3.473 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 3.647762e-04 | 3.438 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 3.647762e-04 | 3.438 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 3.690708e-04 | 3.433 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 3.950698e-04 | 3.403 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.006516e-04 | 3.397 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.096349e-04 | 3.388 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 4.714810e-04 | 3.327 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 4.824227e-04 | 3.317 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 4.932778e-04 | 3.307 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 5.404297e-04 | 3.267 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 5.787402e-04 | 3.238 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 6.231494e-04 | 3.205 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 6.957267e-04 | 3.158 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 9.549891e-04 | 3.020 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.015460e-03 | 2.993 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.126845e-03 | 2.948 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 1.248866e-03 | 2.903 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.417872e-03 | 2.848 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 1.469336e-03 | 2.833 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.554302e-03 | 2.808 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.712778e-03 | 2.766 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.980019e-03 | 2.703 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.589000e-03 | 2.587 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.854093e-03 | 2.732 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.572291e-03 | 2.590 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.725799e-03 | 2.565 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.757125e-03 | 2.560 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 2.774283e-03 | 2.557 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.989882e-03 | 2.524 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.002962e-03 | 2.522 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.057492e-03 | 2.515 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 3.131332e-03 | 2.504 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 3.481676e-03 | 2.458 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 3.699372e-03 | 2.432 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.240979e-03 | 2.373 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 4.424149e-03 | 2.354 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 4.646030e-03 | 2.333 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 4.744264e-03 | 2.324 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 4.926714e-03 | 2.307 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 5.536037e-03 | 2.257 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 5.554888e-03 | 2.255 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 5.573473e-03 | 2.254 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 5.573473e-03 | 2.254 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 5.703515e-03 | 2.244 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 5.712078e-03 | 2.243 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 5.939632e-03 | 2.226 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 6.115858e-03 | 2.214 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.803528e-03 | 2.167 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 6.803528e-03 | 2.167 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 7.297174e-03 | 2.137 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 7.302061e-03 | 2.137 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 7.927466e-03 | 2.101 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 8.137844e-03 | 2.089 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 8.137844e-03 | 2.089 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 8.167082e-03 | 2.088 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 9.034056e-03 | 2.044 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 9.642613e-03 | 2.016 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 9.642613e-03 | 2.016 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 1.122724e-02 | 1.950 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.165704e-02 | 1.933 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 1.200546e-02 | 1.921 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.413041e-02 | 1.850 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.447609e-02 | 1.839 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.609888e-02 | 1.793 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.613629e-02 | 1.792 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.636546e-02 | 1.786 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.660769e-02 | 1.780 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.712700e-02 | 1.766 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.712700e-02 | 1.766 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.743880e-02 | 1.758 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.759841e-02 | 1.755 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.764279e-02 | 1.753 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 1.808990e-02 | 1.743 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 1.915452e-02 | 1.718 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 2.065853e-02 | 1.685 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.068967e-02 | 1.684 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.245605e-02 | 1.649 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.287128e-02 | 1.641 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.405086e-02 | 1.619 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.405086e-02 | 1.619 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH3 | R-HSA-5632927 | 2.405086e-02 | 1.619 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.750311e-02 | 1.561 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 2.905682e-02 | 1.537 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.994841e-02 | 1.524 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 3.026821e-02 | 1.519 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.247676e-02 | 1.488 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 3.508582e-02 | 1.455 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.508582e-02 | 1.455 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 3.508582e-02 | 1.455 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 3.585959e-02 | 1.445 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 3.585959e-02 | 1.445 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 3.585959e-02 | 1.445 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 3.585959e-02 | 1.445 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 3.585959e-02 | 1.445 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 3.585959e-02 | 1.445 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 3.696697e-02 | 1.432 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 3.762647e-02 | 1.425 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.777329e-02 | 1.423 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 3.777329e-02 | 1.423 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 3.819611e-02 | 1.418 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 4.053690e-02 | 1.392 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.752615e-02 | 1.323 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 4.752615e-02 | 1.323 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.752615e-02 | 1.323 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.752615e-02 | 1.323 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.752615e-02 | 1.323 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.752615e-02 | 1.323 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.752615e-02 | 1.323 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.752615e-02 | 1.323 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.752615e-02 | 1.323 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.752615e-02 | 1.323 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.752615e-02 | 1.323 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.752615e-02 | 1.323 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 8.168980e-02 | 1.088 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 4.628376e-02 | 1.335 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 5.859655e-02 | 1.232 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 6.010010e-02 | 1.221 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.561369e-02 | 1.121 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 6.183348e-02 | 1.209 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 7.189410e-02 | 1.143 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 5.905226e-02 | 1.229 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.561369e-02 | 1.121 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.752615e-02 | 1.323 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 5.905226e-02 | 1.229 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 7.043959e-02 | 1.152 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 8.168980e-02 | 1.088 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 4.931343e-02 | 1.307 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 4.628376e-02 | 1.335 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 4.752615e-02 | 1.323 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 4.752615e-02 | 1.323 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 7.043959e-02 | 1.152 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 5.542112e-02 | 1.256 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 6.010010e-02 | 1.221 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 5.942349e-02 | 1.226 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 7.043959e-02 | 1.152 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 6.183348e-02 | 1.209 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 7.535804e-02 | 1.123 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 7.947711e-02 | 1.100 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 6.512998e-02 | 1.186 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 4.581233e-02 | 1.339 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 5.542112e-02 | 1.256 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 7.189410e-02 | 1.143 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 7.726220e-02 | 1.112 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 5.230916e-02 | 1.281 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 5.230916e-02 | 1.281 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 4.759031e-02 | 1.322 | 1 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 6.183348e-02 | 1.209 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 5.542112e-02 | 1.256 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 5.859655e-02 | 1.232 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 6.687884e-02 | 1.175 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 8.860857e-02 | 1.053 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 8.971834e-02 | 1.047 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 8.971834e-02 | 1.047 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.971834e-02 | 1.047 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 9.280454e-02 | 1.032 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 9.280454e-02 | 1.032 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 9.280454e-02 | 1.032 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 9.280454e-02 | 1.032 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 9.333270e-02 | 1.030 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.717748e-02 | 1.012 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.717748e-02 | 1.012 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 1.037854e-01 | 0.984 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 1.048053e-01 | 0.980 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 1.048053e-01 | 0.980 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 1.086786e-01 | 0.964 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.146341e-01 | 0.941 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 1.146341e-01 | 0.941 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.165366e-01 | 0.934 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.205183e-01 | 0.919 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.210389e-01 | 0.917 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.237198e-01 | 0.908 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.245333e-01 | 0.905 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.245333e-01 | 0.905 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.245333e-01 | 0.905 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.253521e-01 | 0.902 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.253521e-01 | 0.902 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.253521e-01 | 0.902 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.253521e-01 | 0.902 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 1.285802e-01 | 0.891 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.285802e-01 | 0.891 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.309242e-01 | 0.883 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 1.326577e-01 | 0.877 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.326577e-01 | 0.877 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.326577e-01 | 0.877 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.347397e-01 | 0.871 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.359410e-01 | 0.867 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.359410e-01 | 0.867 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.359410e-01 | 0.867 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.359410e-01 | 0.867 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.359410e-01 | 0.867 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 1.359410e-01 | 0.867 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.408990e-01 | 0.851 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 1.408990e-01 | 0.851 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 1.408990e-01 | 0.851 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.408990e-01 | 0.851 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.457111e-01 | 0.837 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.464023e-01 | 0.834 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.464023e-01 | 0.834 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.464023e-01 | 0.834 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.464023e-01 | 0.834 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.464023e-01 | 0.834 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.513986e-01 | 0.820 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.567376e-01 | 0.805 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.567376e-01 | 0.805 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 1.567376e-01 | 0.805 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.567376e-01 | 0.805 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 1.567376e-01 | 0.805 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.567376e-01 | 0.805 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 1.567376e-01 | 0.805 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.571561e-01 | 0.804 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 1.576922e-01 | 0.802 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.621337e-01 | 0.790 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.662247e-01 | 0.779 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.669485e-01 | 0.777 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 1.669485e-01 | 0.777 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 1.669485e-01 | 0.777 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 1.669485e-01 | 0.777 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 1.669485e-01 | 0.777 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.669485e-01 | 0.777 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 1.688693e-01 | 0.772 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.705209e-01 | 0.768 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.705209e-01 | 0.768 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 1.770363e-01 | 0.752 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.770363e-01 | 0.752 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.770363e-01 | 0.752 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.770363e-01 | 0.752 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.770363e-01 | 0.752 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.770363e-01 | 0.752 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.835165e-01 | 0.736 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.870025e-01 | 0.728 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.870025e-01 | 0.728 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.870025e-01 | 0.728 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.870025e-01 | 0.728 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.870025e-01 | 0.728 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.870025e-01 | 0.728 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.870025e-01 | 0.728 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 1.930071e-01 | 0.714 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 1.968487e-01 | 0.706 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.968487e-01 | 0.706 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.968487e-01 | 0.706 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 1.968487e-01 | 0.706 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 2.065762e-01 | 0.685 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.065762e-01 | 0.685 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 2.065762e-01 | 0.685 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.065762e-01 | 0.685 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 2.065762e-01 | 0.685 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 2.073851e-01 | 0.683 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 2.073851e-01 | 0.683 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 2.085092e-01 | 0.681 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 2.098967e-01 | 0.678 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 2.098967e-01 | 0.678 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.161865e-01 | 0.665 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 2.161865e-01 | 0.665 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 2.161865e-01 | 0.665 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 2.161865e-01 | 0.665 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 2.187774e-01 | 0.660 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 2.225965e-01 | 0.652 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.256810e-01 | 0.647 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 2.256810e-01 | 0.647 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.256810e-01 | 0.647 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.350611e-01 | 0.629 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.350611e-01 | 0.629 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 2.350611e-01 | 0.629 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 2.350611e-01 | 0.629 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 2.350611e-01 | 0.629 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 2.370592e-01 | 0.625 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 2.411040e-01 | 0.618 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 2.443281e-01 | 0.612 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.443281e-01 | 0.612 | 0 | 0 |
| PKA activation | R-HSA-163615 | 2.443281e-01 | 0.612 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.443281e-01 | 0.612 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.443281e-01 | 0.612 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 2.467267e-01 | 0.608 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 2.500678e-01 | 0.602 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 2.500678e-01 | 0.602 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.534834e-01 | 0.596 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 2.534834e-01 | 0.596 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.534834e-01 | 0.596 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 2.545538e-01 | 0.594 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 2.545538e-01 | 0.594 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 2.625283e-01 | 0.581 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.625283e-01 | 0.581 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.625283e-01 | 0.581 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.625283e-01 | 0.581 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.635303e-01 | 0.579 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.714642e-01 | 0.566 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.714642e-01 | 0.566 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 2.714642e-01 | 0.566 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 2.714642e-01 | 0.566 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.714642e-01 | 0.566 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.802924e-01 | 0.552 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.802924e-01 | 0.552 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 2.802924e-01 | 0.552 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.802924e-01 | 0.552 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.802924e-01 | 0.552 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.802924e-01 | 0.552 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 2.802924e-01 | 0.552 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 2.814828e-01 | 0.551 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.814828e-01 | 0.551 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 2.859105e-01 | 0.544 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.890141e-01 | 0.539 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 2.890141e-01 | 0.539 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 2.890141e-01 | 0.539 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 2.890141e-01 | 0.539 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.890141e-01 | 0.539 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.904486e-01 | 0.537 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 2.976307e-01 | 0.526 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 2.976307e-01 | 0.526 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 2.976307e-01 | 0.526 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.976307e-01 | 0.526 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 3.061434e-01 | 0.514 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.061434e-01 | 0.514 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 3.061434e-01 | 0.514 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 3.061434e-01 | 0.514 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 3.090333e-01 | 0.510 | 0 | 0 |
| Translation | R-HSA-72766 | 3.092107e-01 | 0.510 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 3.127944e-01 | 0.505 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 3.145534e-01 | 0.502 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 3.145534e-01 | 0.502 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.145534e-01 | 0.502 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.145534e-01 | 0.502 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 3.145534e-01 | 0.502 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 3.145534e-01 | 0.502 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 3.145534e-01 | 0.502 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 3.216939e-01 | 0.493 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.228620e-01 | 0.491 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 3.228620e-01 | 0.491 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 3.228620e-01 | 0.491 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 3.305651e-01 | 0.481 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.310704e-01 | 0.480 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.310704e-01 | 0.480 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 3.310704e-01 | 0.480 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.391798e-01 | 0.470 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.391798e-01 | 0.470 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.391798e-01 | 0.470 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.391798e-01 | 0.470 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.391798e-01 | 0.470 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 3.391798e-01 | 0.470 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 3.454463e-01 | 0.462 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.471913e-01 | 0.459 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 3.471913e-01 | 0.459 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 3.471913e-01 | 0.459 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.471913e-01 | 0.459 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.471913e-01 | 0.459 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.471913e-01 | 0.459 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.471913e-01 | 0.459 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.482077e-01 | 0.458 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.487530e-01 | 0.457 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 3.520581e-01 | 0.453 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 3.542078e-01 | 0.451 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.551063e-01 | 0.450 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.551063e-01 | 0.450 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 3.551063e-01 | 0.450 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.551063e-01 | 0.450 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 3.569721e-01 | 0.447 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 3.569721e-01 | 0.447 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 3.600894e-01 | 0.444 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 3.613387e-01 | 0.442 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 3.629257e-01 | 0.440 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.629257e-01 | 0.440 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.656944e-01 | 0.437 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.685517e-01 | 0.434 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 3.700387e-01 | 0.432 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.706509e-01 | 0.431 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.706509e-01 | 0.431 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.743713e-01 | 0.427 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.782828e-01 | 0.422 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.782828e-01 | 0.422 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.782828e-01 | 0.422 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 3.782828e-01 | 0.422 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.782828e-01 | 0.422 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.858226e-01 | 0.414 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 3.932715e-01 | 0.405 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 4.006304e-01 | 0.397 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 4.006304e-01 | 0.397 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 4.006304e-01 | 0.397 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 4.077928e-01 | 0.390 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 4.079006e-01 | 0.389 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 4.079006e-01 | 0.389 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 4.079006e-01 | 0.389 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 4.079006e-01 | 0.389 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 4.085715e-01 | 0.389 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 4.150830e-01 | 0.382 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 4.169822e-01 | 0.380 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 4.221788e-01 | 0.375 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 4.291889e-01 | 0.367 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 4.291889e-01 | 0.367 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 4.361143e-01 | 0.360 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 4.361143e-01 | 0.360 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 4.361143e-01 | 0.360 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 4.361143e-01 | 0.360 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 4.361143e-01 | 0.360 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 4.361143e-01 | 0.360 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 4.361143e-01 | 0.360 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 4.429562e-01 | 0.354 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 4.429562e-01 | 0.354 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 4.429562e-01 | 0.354 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 4.497155e-01 | 0.347 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 4.497155e-01 | 0.347 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 4.497155e-01 | 0.347 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 4.563932e-01 | 0.341 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 4.629902e-01 | 0.334 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 4.661191e-01 | 0.332 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 4.695076e-01 | 0.328 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 4.695076e-01 | 0.328 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.695076e-01 | 0.328 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 4.695076e-01 | 0.328 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 4.740717e-01 | 0.324 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 4.759463e-01 | 0.322 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 4.759463e-01 | 0.322 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.759463e-01 | 0.322 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 4.806930e-01 | 0.318 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 4.823072e-01 | 0.317 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.823072e-01 | 0.317 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.823072e-01 | 0.317 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 4.823072e-01 | 0.317 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 4.823072e-01 | 0.317 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 4.823072e-01 | 0.317 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 4.897614e-01 | 0.310 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 4.947996e-01 | 0.306 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 4.947996e-01 | 0.306 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 4.947996e-01 | 0.306 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 5.009328e-01 | 0.300 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 5.069920e-01 | 0.295 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 5.080843e-01 | 0.294 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 5.129779e-01 | 0.290 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 5.129779e-01 | 0.290 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 5.140700e-01 | 0.289 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 5.188916e-01 | 0.285 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 5.247338e-01 | 0.280 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 5.305054e-01 | 0.275 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 5.418403e-01 | 0.266 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 5.418403e-01 | 0.266 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 5.418403e-01 | 0.266 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 5.474052e-01 | 0.262 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 5.474052e-01 | 0.262 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 5.529028e-01 | 0.257 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 5.583341e-01 | 0.253 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 5.583341e-01 | 0.253 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 5.583341e-01 | 0.253 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 5.636996e-01 | 0.249 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 5.671473e-01 | 0.246 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 5.690003e-01 | 0.245 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 5.690003e-01 | 0.245 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 5.690003e-01 | 0.245 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 5.845211e-01 | 0.233 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 5.845211e-01 | 0.233 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 5.895701e-01 | 0.229 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 5.994857e-01 | 0.222 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 5.994857e-01 | 0.222 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 6.042030e-01 | 0.219 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 6.043538e-01 | 0.219 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 6.043538e-01 | 0.219 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 6.068372e-01 | 0.217 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 6.138778e-01 | 0.212 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 6.139140e-01 | 0.212 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 6.139140e-01 | 0.212 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 6.278250e-01 | 0.202 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.323503e-01 | 0.199 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 6.326979e-01 | 0.199 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 6.368209e-01 | 0.196 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 6.368209e-01 | 0.196 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 6.412373e-01 | 0.193 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.583752e-01 | 0.182 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.625308e-01 | 0.179 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 6.710165e-01 | 0.173 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.746984e-01 | 0.171 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 6.825665e-01 | 0.166 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 6.825665e-01 | 0.166 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.825665e-01 | 0.166 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 6.825665e-01 | 0.166 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.864293e-01 | 0.163 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 6.864293e-01 | 0.163 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 6.902454e-01 | 0.161 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 7.014185e-01 | 0.154 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 7.014185e-01 | 0.154 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 7.014185e-01 | 0.154 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 7.050530e-01 | 0.152 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 7.068258e-01 | 0.151 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 7.086435e-01 | 0.150 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 7.186787e-01 | 0.143 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 7.191562e-01 | 0.143 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 7.225758e-01 | 0.141 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 7.259541e-01 | 0.139 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 7.292914e-01 | 0.137 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 7.358452e-01 | 0.133 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 7.358452e-01 | 0.133 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 7.422411e-01 | 0.129 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 7.453810e-01 | 0.128 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 7.515472e-01 | 0.124 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 7.538591e-01 | 0.123 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.545744e-01 | 0.122 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.634374e-01 | 0.117 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 7.663204e-01 | 0.116 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 7.663204e-01 | 0.116 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 7.663204e-01 | 0.116 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.691684e-01 | 0.114 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.802193e-01 | 0.108 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.802193e-01 | 0.108 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 7.802193e-01 | 0.108 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 7.871597e-01 | 0.104 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 7.881606e-01 | 0.103 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 7.932955e-01 | 0.101 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.983066e-01 | 0.098 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 8.077053e-01 | 0.093 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 8.129954e-01 | 0.090 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 8.173639e-01 | 0.088 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 8.259338e-01 | 0.083 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 8.342788e-01 | 0.079 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 8.363021e-01 | 0.078 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.460558e-01 | 0.073 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 8.497934e-01 | 0.071 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 8.587470e-01 | 0.066 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 8.655260e-01 | 0.063 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 8.671695e-01 | 0.062 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 8.687931e-01 | 0.061 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 8.719812e-01 | 0.059 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 8.719812e-01 | 0.059 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.750922e-01 | 0.058 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 8.793087e-01 | 0.056 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.796183e-01 | 0.056 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 8.825446e-01 | 0.054 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.825446e-01 | 0.054 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.839811e-01 | 0.054 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 8.868019e-01 | 0.052 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.922405e-01 | 0.050 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 8.961480e-01 | 0.048 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.023499e-01 | 0.045 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.104181e-01 | 0.041 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.188297e-01 | 0.037 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.217773e-01 | 0.035 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.489393e-01 | 0.023 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.589246e-01 | 0.018 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.671848e-01 | 0.014 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.676526e-01 | 0.014 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.709041e-01 | 0.013 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.755407e-01 | 0.011 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 9.883961e-01 | 0.005 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.906737e-01 | 0.004 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.931265e-01 | 0.003 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.940088e-01 | 0.003 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.942292e-01 | 0.003 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.955001e-01 | 0.002 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.960347e-01 | 0.002 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.967465e-01 | 0.001 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.995257e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999966e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 9.999998e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.000000e+00 | 0.000 | 1 | 1 |